FR3046066A1 - COMPOSITION BASED ON SPICULISPORIC ACID - Google Patents
COMPOSITION BASED ON SPICULISPORIC ACID Download PDFInfo
- Publication number
- FR3046066A1 FR3046066A1 FR1563240A FR1563240A FR3046066A1 FR 3046066 A1 FR3046066 A1 FR 3046066A1 FR 1563240 A FR1563240 A FR 1563240A FR 1563240 A FR1563240 A FR 1563240A FR 3046066 A1 FR3046066 A1 FR 3046066A1
- Authority
- FR
- France
- Prior art keywords
- composition
- composition according
- acid
- skin
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 152
- TUXHHVJPGQUPCF-UHFFFAOYSA-N Spiculisporic acid Natural products CCCCCCCCCCC(C(O)=O)C1(C(O)=O)CCC(=O)O1 TUXHHVJPGQUPCF-UHFFFAOYSA-N 0.000 title claims abstract description 36
- TUXHHVJPGQUPCF-DYVFJYSZSA-N (-)-Spiculisporic acid Chemical compound CCCCCCCCCC[C@H](C(O)=O)[C@]1(C(O)=O)CCC(=O)O1 TUXHHVJPGQUPCF-DYVFJYSZSA-N 0.000 title claims abstract description 35
- 150000003077 polyols Chemical class 0.000 claims abstract description 21
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920005862 polyol Polymers 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000002334 glycols Chemical class 0.000 claims abstract description 4
- 239000007764 o/w emulsion Substances 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 21
- 239000000049 pigment Substances 0.000 claims description 20
- 102000011782 Keratins Human genes 0.000 claims description 18
- 108010076876 Keratins Proteins 0.000 claims description 18
- 239000012071 phase Substances 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 15
- 239000003344 environmental pollutant Substances 0.000 claims description 13
- 231100000719 pollutant Toxicity 0.000 claims description 13
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000000945 filler Substances 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 239000010419 fine particle Substances 0.000 claims description 9
- 239000003349 gelling agent Substances 0.000 claims description 9
- 150000002430 hydrocarbons Chemical class 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 8
- 239000004904 UV filter Substances 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 206010039792 Seborrhoea Diseases 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 239000006229 carbon black Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 230000004075 alteration Effects 0.000 claims description 4
- 229910002090 carbon oxide Inorganic materials 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229910001385 heavy metal Inorganic materials 0.000 claims description 4
- 230000037312 oily skin Effects 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000012855 volatile organic compound Substances 0.000 claims description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 229940031439 squalene Drugs 0.000 claims description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims description 3
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052815 sulfur oxide Inorganic materials 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000009826 distribution Methods 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229940102253 isopropanolamine Drugs 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- 150000003464 sulfur compounds Chemical class 0.000 claims 1
- 239000000839 emulsion Substances 0.000 description 21
- 125000004432 carbon atom Chemical group C* 0.000 description 19
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- -1 polymethylsiloxanes Polymers 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000284 extract Substances 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 229910052618 mica group Inorganic materials 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 239000002781 deodorant agent Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000010445 mica Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000012860 organic pigment Substances 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003570 air Substances 0.000 description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000002191 fatty alcohols Chemical group 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 229960004889 salicylic acid Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 150000001277 beta hydroxy acids Chemical class 0.000 description 5
- 150000004665 fatty acids Chemical group 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 4
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229940073609 bismuth oxychloride Drugs 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 4
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 4
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 239000003021 water soluble solvent Substances 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229940061720 alpha hydroxy acid Drugs 0.000 description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 3
- 230000001153 anti-wrinkle effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000004581 coalescence Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000007854 depigmenting agent Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000003410 keratolytic agent Substances 0.000 description 3
- 239000004922 lacquer Substances 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical group CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- XMVBHZBLHNOQON-UHFFFAOYSA-N 2-butyl-1-octanol Chemical compound CCCCCCC(CO)CCCC XMVBHZBLHNOQON-UHFFFAOYSA-N 0.000 description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 2
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 206010001488 Aggression Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000125183 Crithmum maritimum Species 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001484 arginines Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical group C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 2
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 2
- 238000010907 mechanical stirring Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229940094933 n-dodecane Drugs 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 230000010363 phase shift Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- DMPUWIFOFJMCFN-UHFFFAOYSA-N (2-nitro-9H-xanthen-1-yl)-(9H-xanthen-1-yl)diazene Chemical compound O1C2=CC=CC=C2CC2=C1C=CC=C2N=NC1=C2CC3=CC=CC=C3OC2=CC=C1[N+](=O)[O-] DMPUWIFOFJMCFN-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- RTBWWWVNZWFNBV-SFHVURJKSA-N (2s)-3-phenyl-2-(undec-10-enoylamino)propanoic acid Chemical compound C=CCCCCCCCCC(=O)N[C@H](C(=O)O)CC1=CC=CC=C1 RTBWWWVNZWFNBV-SFHVURJKSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- BMLMGCPTLHPWPY-REOHCLBHSA-N (4R)-2-oxo-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSC(=O)N1 BMLMGCPTLHPWPY-REOHCLBHSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
- JUOGWHAEZWRBMM-UHFFFAOYSA-N 1-ethoxyhexane;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCOCC JUOGWHAEZWRBMM-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- AZXGXVQWEUFULR-UHFFFAOYSA-N 2',4',5',7'-tetrabromofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 AZXGXVQWEUFULR-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- GJUXFTUISAQMQE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)C(=O)OCC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 GJUXFTUISAQMQE-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FWLHAQYOFMQTHQ-UHFFFAOYSA-N 2-N-[8-[[8-(4-aminoanilino)-10-phenylphenazin-10-ium-2-yl]amino]-10-phenylphenazin-10-ium-2-yl]-8-N,10-diphenylphenazin-10-ium-2,8-diamine hydroxy-oxido-dioxochromium Chemical compound O[Cr]([O-])(=O)=O.O[Cr]([O-])(=O)=O.O[Cr]([O-])(=O)=O.Nc1ccc(Nc2ccc3nc4ccc(Nc5ccc6nc7ccc(Nc8ccc9nc%10ccc(Nc%11ccccc%11)cc%10[n+](-c%10ccccc%10)c9c8)cc7[n+](-c7ccccc7)c6c5)cc4[n+](-c4ccccc4)c3c2)cc1 FWLHAQYOFMQTHQ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- BPNCGOJZFFCWCX-UHFFFAOYSA-N 2-[1-(2-ethylphenyl)heptylidene]-1,3-dimethoxyimidazolidine-4,5-dione Chemical compound C=1C=CC=C(CC)C=1C(CCCCCC)=C1N(OC)C(=O)C(=O)N1OC BPNCGOJZFFCWCX-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- DMQQXDPCRUGSQB-UHFFFAOYSA-N 2-[3-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCCN(CC(O)=O)CC(O)=O DMQQXDPCRUGSQB-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- JIDBIDDEFPKZDG-UHFFFAOYSA-N 2-[[2-[n-acetyl-3-(trifluoromethyl)anilino]-3-methylbutanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)C(C(C)C)N(C(C)=O)C1=CC=CC(C(F)(F)F)=C1 JIDBIDDEFPKZDG-UHFFFAOYSA-N 0.000 description 1
- WYMDDFRYORANCC-UHFFFAOYSA-N 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)CN(CC(O)=O)CC(O)=O WYMDDFRYORANCC-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- UVSHZSVDEWHXMF-UHFFFAOYSA-N 2-hydroxy-n-(3,4,5-trichlorophenyl)benzamide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC(Cl)=C(Cl)C(Cl)=C1 UVSHZSVDEWHXMF-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- CYSSSYKSBHKJQE-UHFFFAOYSA-N 2-undecylpentadecan-1-ol Chemical compound CCCCCCCCCCCCCC(CO)CCCCCCCCCCC CYSSSYKSBHKJQE-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- YURFJRIDNKGUDV-UHFFFAOYSA-N 3,7,11-trimethyldodeca-2,5,10-trien-1-ol Chemical compound CC(C)=CCCC(C)C=CCC(C)=CCO YURFJRIDNKGUDV-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- NCYQVRNLBAYSLE-UHFFFAOYSA-N 4-methyl-4-phenylpentan-2-ol Chemical compound CC(O)CC(C)(C)C1=CC=CC=C1 NCYQVRNLBAYSLE-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000033316 Acquired hemophilia A Diseases 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000012284 Bertholletia excelsa Nutrition 0.000 description 1
- 244000205479 Bertholletia excelsa Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- HMEKVHWROSNWPD-UHFFFAOYSA-N Erioglaucine A Chemical compound [NH4+].[NH4+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 HMEKVHWROSNWPD-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- JFHCDEYLWGVZMX-CMDGGOBGSA-N Isoamyl cinnamate Chemical compound CC(C)CCOC(=O)\C=C\C1=CC=CC=C1 JFHCDEYLWGVZMX-CMDGGOBGSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 240000003935 Sclerocarya birrea Species 0.000 description 1
- 235000001836 Sclerocarya caffra Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 229910018557 Si O Inorganic materials 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 235000010725 Vigna aconitifolia Nutrition 0.000 description 1
- 244000042325 Vigna aconitifolia Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- ZPFXAOWNKLFJDN-UHFFFAOYSA-N alverine Chemical compound C=1C=CC=CC=1CCCN(CC)CCCC1=CC=CC=C1 ZPFXAOWNKLFJDN-UHFFFAOYSA-N 0.000 description 1
- 229960000845 alverine Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 229960004101 bemotrizinol Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- OHXVIZBSLGZEFS-UHFFFAOYSA-N benzhydrylsilyloxy-diphenyl-silyloxysilane Chemical class C1(=CC=CC=C1)C(C1=CC=CC=C1)[SiH2]O[Si](O[SiH3])(C1=CC=CC=C1)C1=CC=CC=C1 OHXVIZBSLGZEFS-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical class CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical class C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical class CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- PPSZHCXTGRHULJ-UHFFFAOYSA-N dioxazine Chemical compound O1ON=CC=C1 PPSZHCXTGRHULJ-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960000979 drometrizole Drugs 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- AIPVRBGBHQDAPX-UHFFFAOYSA-N hydroxy(methyl)silane Chemical compound C[SiH2]O AIPVRBGBHQDAPX-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- YODZNEIDVLFIIC-UHFFFAOYSA-N icosan-10-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCCCC YODZNEIDVLFIIC-UHFFFAOYSA-N 0.000 description 1
- LTYSCLBTUYRCBF-UHFFFAOYSA-N icosan-9-yl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OC(CCCCCCCC)CCCCCCCCCCC LTYSCLBTUYRCBF-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical compound C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- PVWXTVUZGJXFJQ-CCEZHUSRSA-N methyl (E)-4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(\C(C)C)=C(/C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-CCEZHUSRSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- WFMCQEFBENUYHI-UHFFFAOYSA-N n,n'-bis[(3,4,5-trimethoxyphenyl)methyl]ethane-1,2-diamine Chemical compound COC1=C(OC)C(OC)=CC(CNCCNCC=2C=C(OC)C(OC)=C(OC)C=2)=C1 WFMCQEFBENUYHI-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002832 nitroso derivatives Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 125000005473 octanoic acid group Chemical class 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- DGBWPZSGHAXYGK-UHFFFAOYSA-N perinone Chemical compound C12=NC3=CC=CC=C3N2C(=O)C2=CC=C3C4=C2C1=CC=C4C(=O)N1C2=CC=CC=C2N=C13 DGBWPZSGHAXYGK-UHFFFAOYSA-N 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229940106025 phenylethyl resorcinol Drugs 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- FYNROBRQIVCIQF-UHFFFAOYSA-N pyrrolo[3,2-b]pyrrole-5,6-dione Chemical compound C1=CN=C2C(=O)C(=O)N=C21 FYNROBRQIVCIQF-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- JOUDBUYBGJYFFP-FOCLMDBBSA-N thioindigo Chemical compound S\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2S1 JOUDBUYBGJYFFP-FOCLMDBBSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- 229940100142 zinc pidolate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
Abstract
Composition sous la forme d'une émulsion huile dans l'eau comprenant : de 0,1 à 15 %, en poids d'acide spiculisporique par rapport au poids total de la composition, au moins une base choisie parmi les acides aminés et les alcanolamines en une quantité apte à former au moins le monosel de l'acide spiculisporique, ladite composition comprenant moins de 3 %, de préférence moins de 1 % en poids de glycol(s) et/ou de polyol(s) par rapport au poids total de la composition avantageusement étant dénuée de glycols et/ou de polyol(s).Composition in the form of an oil-in-water emulsion comprising: from 0.1 to 15% by weight of spiculisporic acid relative to the total weight of the composition, at least one base chosen from amino acids and alkanolamines in an amount capable of forming at least the monosel of spiculisporic acid, said composition comprising less than 3%, preferably less than 1% by weight of glycol (s) and / or polyol (s) relative to the total weight the composition advantageously being devoid of glycols and / or polyol (s).
Description
La présente invention concerne le domaine des compositions filmogènes utilisables en cosmétique, plus particulièrement elle vise les émulsions présentant des propriétés filmogènes. L’obtention de compositions susceptibles de former un film stable et homogène est un problème technique récurrent dans de nombreux domaines et plus particulièrement en cosmétique comme par exemple pour des applications en tant que crèmes, déodorants, mascaras, vernis à ongles, produits de soin et/ou de maquillage.The present invention relates to the field of film-forming compositions that can be used in cosmetics, more particularly it relates to emulsions having film-forming properties. Obtaining compositions capable of forming a stable and homogeneous film is a recurring technical problem in many fields and more particularly in cosmetics, for example for applications as creams, deodorants, mascaras, nail polishes, skincare products and / or makeup.
En effet de nombreux produits cosmétiques, grâce à cette propriété filmogène, vont voir leurs propriétés améliorées que ce soit en terme de dispersion des composants, de toucher ou encore d’effet barrière entre le support sur lequel a été appliquée la composition et le milieu extérieur. Généralement pour obtenir ce genre de compositions, on utilise principalement des polymères filmogènes conventionnels, en outre quand l’obtention d’une émulsion est visée, on utilise de préférence des molécules tensio-actives synthétiques à propriété filmogène généralement issues du pétrole.Indeed, many cosmetic products, thanks to this film-forming property, will see their improved properties whether in terms of dispersion of components, touch or barrier effect between the support on which the composition was applied and the external environment. . Generally, in order to obtain this type of composition, conventional film-forming polymers are used, in addition, when obtaining an emulsion is targeted, synthetic film-forming surfactant molecules generally derived from petroleum are preferably used.
Cependant la plupart des molécules tensio-actives synthétiques à propriété filmogène issues du pétrole utilisées dans les diverses industries sont délétères pour l’environnement.However, most of the film-forming synthetic surfactant molecules from petroleum used in various industries are deleterious to the environment.
De plus, les tensioactifs synthétiques sont certes de bons émulsionnants mais conduisent pour la plupart à la formation de films sensibles à l’humidité et faiblement cohésifs.In addition, synthetic surfactants are certainly good emulsifiers but lead for the most part to the formation of moisture-sensitive and weakly cohesive films.
Il demeure par conséquent un besoin de systèmes émulsionnants filmogènes, qui soient respectueux de l’environnement.There is therefore a need for film-forming emulsifying systems, which are respectful of the environment.
Par ailleurs, la peau et le cuir chevelu humain sont les premières barrières protégeant le corps de l’environnement. Chaque jour, ces derniers subissent des agressions externes, qui sont responsables de nombreux problèmes de peau, tels que le vieillissement accéléré, des affections de la peau, un incomfort, ou l’état graisseux de la peau, etc.In addition, the skin and the human scalp are the first barriers protecting the body from the environment. Each day, they suffer external aggressions, which are responsible for many skin problems, such as accelerated aging, skin conditions, discomfort, or the greasy condition of the skin, etc.
En particulier, la pollution atmosphérique, à savoir la quantité de polluants dans l’air, soulève des inquiétudes de plus en plus nombreuses pour les consommateurs, en raison de son impact négatif sur la peau. Parmi les différents types de polluants existant dans l’air, la poussière ou les fines particules telles que les particules ayant un diamètre inférieur à 10 pm (PM10), de préférence inférieur à 2,5μηι (PM2.5), les poudres de carbone. Jes gaz tels que CO, $0¾ NO*, ont attiré rattention des consommateurs, en particulier ces dernières années.In particular, air pollution, ie the amount of pollutants in the air, raises more and more concerns for consumers because of its negative impact on the skin. Among the different types of pollutants in the air, dust or fine particles such as particles having a diameter of less than 10 μm (PM10), preferably less than 2.5 μm (PM2.5), carbon powders . Gases such as CO, $ 0¾ NO *, have attracted consumer attention, particularly in recent years.
Les particules fines existant dans l’air tendent à adhérer à la peau. Elles se déposent ou restent déposées sur la peau même après nettoyage. Ce dépôt n’est pas désiré par le consommateur, dans la mesure où l’on pense que les pores de la peau peuvent être bouchés et conduire ainsi à des problèmes de peau. La pollution atmosphérique est également à l’origine de problèmes de vieillissement cutané (notamment lié au stress oxydatif généré par les particules polluantes, les UV, tabac...), de peau deshydratée ou encore d’augmentation de la séborrhée (Lefebvre et al, 2015, International Journal of Cosmetic science, 37 :329-338). L’état de la technique ne divulgue pas de solutions permettant de prévenir ou de réduire le dépôt des particules fines sur la peau et le cuir chevelu.Fine particles in the air tend to adhere to the skin. They are deposited or remain deposited on the skin even after cleaning. This deposit is not desired by the consumer, since it is believed that the pores of the skin can be clogged and thus lead to skin problems. Air pollution is also at the origin of skin aging problems (particularly related to the oxidative stress generated by polluting particles, UV, tobacco ...), dehydrated skin or increased seborrhea (Lefebvre et al. , 2015, International Journal of Cosmetic Science, 37: 329-338). The state of the art does not disclose solutions to prevent or reduce the deposition of fine particles on the skin and scalp.
Il existe donc un besoin fort pour la préparation de compositions possédant un effet anti-déposition contre les particules fines. Plus particulièrement, il existe un besoin pour des compositions présentant des propriétés bénéfiques d’anti-déposition en plus d’autres propriétés, telles que par exemple des propriétés d’hydratation ou d’amélioration de la douceur, après application sur les matières kératiniques, en particulier sur la peau ou le cuir chevelu. Il est en outre avantageux que de telles compositions soient capables de présenter les effets décrits ci-dessus pendant une durée relativement longue, par exemple pendant 6 à 8 heures.There is therefore a strong need for the preparation of compositions having an anti-deposition effect against fine particles. More particularly, there is a need for compositions having beneficial properties of anti-deposition in addition to other properties, such as for example properties of hydration or amelioration of softness, after application to keratin materials, especially on the skin or the scalp. It is furthermore advantageous that such compositions are capable of exhibiting the effects described above for a relatively long time, for example for 6 to 8 hours.
Les auteurs de la présente invention ont montré que ce problème pouvait être résolu en utilisant des sels particuliers d’acide spieulisporique. L’acide spieulisporique est un biotensioactif émulsionnant issu de microorganisme qui est non toxique pour l’environnement.The present inventors have shown that this problem can be solved by using particular salts of sporisporic acid. Spieulisporic acid is an emulsifying biosurfactant derived from a microorganism that is non-toxic to the environment.
Ainsi la présente invention concerne une composition en particulier cosmétique, sons la forme d’une émulsion huile dans l’eau comprenant une phase huileuse, une phase aqueuse caractérisée en ce qu’elle comprend : de 0,1 à 15 %, de préférence de 0,5 à 10 % et de manière encore plus préférée de 0,7 à 8 %, mieux de 1 à 8% en poids d’acide spieulisporique par rapport au poids total de la composition, au moins une base choisie parmi les acides aminés et les alcanolamines en une quantité apte à former au moins le monosel de l’acide spieulisporique, ladite composition comprenant moins de 3 %, de préférence moins de 1 % en poids de glycol(s) et/ou de polyol(s) par rapport au poids total de la composition, la composition étant avantageusement dénuée de glycols et/ou de polyols.Thus, the present invention relates to a composition, in particular an oil-in-water emulsion comprising an oily phase, an aqueous phase characterized in that it comprises: 0.1 to 15%, preferably 0.5 to 10% and even more preferably 0.7 to 8%, more preferably 1 to 8% by weight of spieulisporique acid relative to the total weight of the composition, at least one base selected from amino acids and the alkanolamines in an amount capable of forming at least the monosel of spieulisporique acid, said composition comprising less than 3%, preferably less than 1% by weight of glycol (s) and / or polyol (s) relative to the total weight of the composition, the composition being advantageously devoid of glycols and / or polyols.
La composition selon l’invention est apte à former un film stable, homogène et résistant sur les matières kératiniques. Les compositions de l’invention possèdent ainsi des propriétés anti-déposition augmentées contre les particules fines, en particulier par la formation de films anti-adhésifs sur les matières kératiniques permettant d’éviter le dépôt des composés polluants sur lesdites matières kératiniques.The composition according to the invention is capable of forming a stable, homogeneous and resistant film on keratin materials. The compositions of the invention thus have enhanced anti-deposition properties against fine particles, in particular by the formation of anti-adhesive films on keratinous substances making it possible to prevent the deposit of pollutant compounds on said keratin materials.
Les composants utilisés présentent notamment des propriétés filmogènes de la phase grasse et permetttent de stabiliser un film que l’on peut qualifier de « film gras ».The components used in particular have film-forming properties of the fatty phase and make it possible to stabilize a film that can be described as a "greasy film".
La présente invention vise ainsi à fournir des compositions destinées à une utilisation pour le soin et/ou le maquillage des matières kératiniques, présentant des propriétés de résistance améliorée à la poussière et aux particules fines, c’est-à-dire possédant un effet anti-dépôt des particules fines sur les matières kératiniques.The present invention thus aims to provide compositions for use in the care and / or makeup of keratinous materials, having improved properties of resistance to dust and fine particles, that is to say having an anti-aging effect. deposition of the fine particles on the keratin materials.
Par conséquent, l’utilisation de l’acide spiculisporique dans le cadre de l’invention permet également de s’affranchir de l’ajout de polymères filmogènes supplémentaires. En effet il est toujours avantageux de pouvoir formuler des compositions comprenant un nombre limité d’ingrédients.Consequently, the use of spiculisporic acid within the scope of the invention also makes it possible to dispense with the addition of additional film-forming polymers. Indeed, it is always advantageous to be able to formulate compositions comprising a limited number of ingredients.
De plus les propriétés émulsionnantes de ce biotensioactif sont au moins de l’ordre de celles des tensioactifs synthétiques, les émulsions H/E selon l’invention sont par conséquent particulièrement stables et homogènes comme montré dans les exemples ci-après.In addition, the emulsifying properties of this biosurfactant are at least of the order of those of the synthetic surfactants, the O / W emulsions according to the invention are therefore particularly stable and homogeneous, as shown in the examples below.
La composition selon l’invention constitue une alternative intéressante aux compositions de l’art antérieur comprenant des tensioactifs synthétiques de par son pouvoir émulsionnant, et de par la stabilité, la rémanence et la résistance à l’humidité des films obtenus apres séchage de ladite composition.The composition according to the invention constitutes an interesting alternative to the compositions of the prior art comprising synthetic surfactants by virtue of its emulsifying power, and by the stability, the remanence and the moisture resistance of the films obtained after drying of said composition. .
La composition selon l’invention est en outre particulièrement respectueuse de l’environnement.The composition according to the invention is also particularly respectful of the environment.
La composition selon l’invention présente en outre l’avantage de pouvoir être formulée en intégrant les ingrédients adéquats pour des applications cosmétiques très diverses telles que des déodorants, mascaras, vernis à ongles, des produits de soin et/ou de maquillage comme des crèmes ou des fonds de teint.The composition according to the invention also has the advantage of being able to be formulated by integrating the appropriate ingredients for very diverse cosmetic applications such as deodorants, mascaras, nail polish, skincare and / or makeup products such as creams. or foundation.
Les compositions obtenues, notamment les produits de soin et/ou de maquillage conduisent en outre à des films présentant des avantages en termes de propriétés sensorielles, notamment un toucher agréable.The compositions obtained, in particular the skincare and / or make-up products, also lead to films having advantages in terms of sensory properties, especially a pleasant feel.
Le film obtenu en appliquant les compositions de soin et/ou de maquillage présente une rupture rapide (propriété connue sous le nom de « quîek breaking » en langue anglaise) mais ce film constitue néanmoins un frein à l’étalement. Cette propriété de constituer un frein à l’application conduit le consommateur à appliquer ladite composition pendant une durée plus longue et avec une pression sur la peau plus importante, ce qui permet une meilleure pénétration des actifs. La disparition du frein peut également constituer un signe d’application achevée et réussie.The film obtained by applying care and / or make-up compositions has a rapid break (property known as "quiek breaking" in English), but this film nonetheless constitutes a brake on spreading. This property of being a brake on the application leads the consumer to apply said composition for a longer duration and with greater pressure on the skin, which allows better penetration of the assets. The disappearance of the brake can also be a sign of completed and successful application.
Selon un deuxième aspect, la présente invention vise F utilisation de la composition selon l’invention en tant que produit de maquillage, de soin, d’hygiène et/ou de nettoyage des matières kératiniques notament de la peau ou des cheveux, en particulier en tant que produit de nettoyage des matières kératiniques.According to a second aspect, the present invention aims at the use of the composition according to the invention as a product for makeup, care, hygiene and / or cleaning of keratinous substances such as skin or hair, in particular in as a cleaning product for keratin materials.
Selon un troisième aspect, la présente invention vise un procédé cosmétique non thérapeutique, de maquillage, de soin, d’hygiène et/ou de nettoyage comprenant une étape d’application de la composition selon l’invention lesdites matières kératiniques.According to a third aspect, the present invention relates to a non-therapeutic cosmetic process, makeup, care, hygiene and / or cleaning comprising a step of applying the composition according to the invention said keratin materials.
Plus particulièrement la composition selon l’invention est une composition de protection des matières kératiniques, plus particulièrement de la peau, vis-à-vis des polluants de l’air.More particularly, the composition according to the invention is a composition for protecting keratin materials, more particularly the skin, against air pollutants.
Ainsi la présente invention vise encore l’utilisation de la composition selon l’invention pour protéger les matières kératiniques vis-à-vis des composés polluants atmosphériques notamment choisis parmi le noir de carbone, les oxydes de carbone, les oxydes d’azote, les oxydes de soufre, les composés hydrocarbonés, les composés organiques volatiles, les métaux lourds, les particules fines PM2.5, PM 10 et leurs mélanges.Thus, the present invention also aims at the use of the composition according to the invention for protecting keratin materials with respect to atmospheric pollutant compounds chosen in particular from carbon black, carbon oxides, nitrogen oxides, sulfur oxides, hydrocarbon compounds, volatile organic compounds, heavy metals, particulate PM2.5, PM10 and mixtures thereof.
Plus particulièrement ladite utilisation vise à protéger les matières kératiniques des désordres dûs aux composés polluants atmosphériques, lesdits désordres étant choisis parmi les peaux grasses, la déshydratation de la peau, l’altération de la desquamation, la diminution du squaîène, la diminution de la vitamine E, la pigraentaion, l’augmentation de l’acide lactique.More particularly, said use is intended to protect keratin materials from disorders due to atmospheric pollutant compounds, said disorders being chosen from oily skin, dehydration of the skin, alteration of desquamation, reduction of squaitene, reduction of vitamin E, pigraentaion, the increase of lactic acid.
La présente invention vise aussi Futilisation de l’acide spiculisporique sous forme partiellement ou totalement neutralisé par une base choisie parmi les acides aminés et les aleanolamines dans une composition, en particulier cosmétique, pour former un film sur la surface des matières kératiniques, notamment sur la peau ou les cheveux, en particulier ladite utilisation est telle que le film formé protège les matières kératiniques vis-à-vis des composés polluants atmosphériques, ou telle que le ftim formé favorise la répartition homogène d’au moins un actif compris dans la composition sur les matières kératiniques, ledit actif étant préférentiellement un filtre UV, de préférence lipophile, et/ou un additif choisi parmi les pigments, les charges ou les nacres.The present invention also relates to the use of spiculisporic acid in form partially or totally neutralized with a base selected from amino acids and aleanolamines in a composition, in particular a cosmetic composition, for forming a film on the surface of keratin materials, in particular on the skin or hair, in particular said use is such that the formed film protects the keratinous substances vis-à-vis atmospheric pollutants, or such that the ftim formed promotes the homogeneous distribution of at least one active ingredient included in the composition. keratin materials, said active agent being preferably a UV filter, preferably a lipophilic filter, and / or an additive chosen from pigments, fillers or nacres.
La présente invention vise aussi un procédé cosmétique non thérapeutique de protection des matières kératiniques vis-à-vis des composés polluants atmosphériques notamment choisis parmi le noir de carbone, les oxydes de carbone, les oxydes d’azote, les oxydes de soufre, les composés hydrocarbonés, les composés organiques volatiles, les métaux lourds, les particules fines PM2.5, PM10 et leurs mélanges.The present invention also relates to a non-therapeutic cosmetic process for protecting keratinous substances against atmospheric pollutant compounds chosen in particular from carbon black, carbon oxides, nitrogen oxides, sulfur oxides, compounds and the like. hydrocarbon compounds, volatile organic compounds, heavy metals, PM2.5, PM10 fine particles and mixtures thereof.
Plus particulièrement ledit procédé vise à protéger les matières kératiniques des déordres dûs aux composés polluants atmosphériques, lesdxts désordres étant choisis parmi les peaux grasses, la déshydratation de la peau, l’altération de la désquamation, la diminution du squalène, la diminution de la vitamine E, la pigmentation, l’augmentation de l’acide lactique. D’autres variantes, avantages et propiétés de P invention seront mis en évidence dans la description et les exemples qui suivent.More particularly, said process is intended to protect keratin materials from disorders due to atmospheric pollutant compounds, the said disorders being chosen from oily skin, dehydration of the skin, the alteration of the quenching, the decrease of squalene, the decrease of the vitamin E, pigmentation, increase of lactic acid. Other variants, advantages and properties of the invention will be highlighted in the description and examples which follow.
Acide spiculisporiqueSpiculisporic acid
La composition sous forme d’émulsion selon rinvention comprend de l’acide spiculisporique, également connu sous le nom de 4,5-dicarboxy-4-pentadécanolide, de formule :The emulsion composition according to the invention comprises spiculisporic acid, also known as 4,5-dicarboxy-4-pentadecanolide, of the formula:
Il est connu que l’acide spiculisporique, encore appelé « acide Sp » dans la suite du texte, est insoluble, à température ambiante, dans l’eau et les corps gras mais qu’il est soluble dans l’éthanol.It is known that spiculisporic acid, also called "Sp acid" in the rest of the text, is insoluble, at room temperature, in water and fatty substances but is soluble in ethanol.
En outre, il est connu que l’acide spiculisporique peut être solubilisé, à température ambiante, par salification.In addition, it is known that spiculisporic acid can be solubilized at room temperature by salification.
Plus exactement, l’acide Sp peut former un mono-sel, un di-sel ou un tri-sel.More exactly, the acid Sp can form a mono-salt, a di-salt or a tri-salt.
Le mono-sel correspond au produit de neutralisation du groupement carboxylique lié à l’atome de carbone en position C4 de l’acide Sp ; le di-sel correspond au produit de neutralisation des groupements carboxyliques liés aux atomes de carbone en position C4 et C5 de l’acide Sp ; le tri-sel correspond au produit de neutralisation des groupements carboxyliques liés aux atomes de carbone en position C4 et C5 de l’acide Sp et de salification de la fonction lactone sous sa forme ouverte.The mono-salt corresponds to the product of neutralization of the carboxylic group bonded to the carbon atom in the C4 position of the acid Sp; the di-salt corresponds to the product of neutralization of the carboxylic groups bonded to the carbon atoms in the C4 and C5 positions of the Sp acid; the tri-salt corresponds to the product of neutralization of the carboxylic groups bonded to the carbon atoms in the C4 and C5 positions of the Sp acid and to the salification of the lactone function in its open form.
Dans les émulsions selon l’invention, l’acide spiculisporique peut être sous forme d’un mono-sel, d’un di-sel, d’un tri-sel ou d’un mélange de plusieurs sels de degré de salification différent.In the emulsions according to the invention, the spiculisporic acid may be in the form of a mono-salt, a di-salt, a tri-salt or a mixture of several salts of different degrees of salification.
Selon un mode de réalisation préféré de l’invention, l’acide spiculisporique est sous forme d’un mono-sel.According to a preferred embodiment of the invention, the spiculisporic acid is in the form of a mono-salt.
Comme déjà mentionné, la quantité d’acide spiculisporique va de 0,1 à 15 %, de préférence de 0,5 à 10% et de manière encore plus préférée de 0,7 à 8 % en poids d’acide spiculisporique par rapport au poids total de la composition.As already mentioned, the amount of spiculisporic acid ranges from 0.1 to 15%, preferably from 0.5 to 10% and even more preferably from 0.7 to 8% by weight of spiculisporic acid relative to total weight of the composition.
En particulier, la quantité d’acide spiculisporique est de 0,6 ;0,7 ;0,8 ;0,9 ;1,0 ;1,1 ;1,2 ;1,3 ;1,4 ;1,5, 2 ;3 ;4 ; 5 ; 6 ; 7 ; 8 ; 9 ; 10 % en poids par rapport au poids total de la composition.In particular, the amount of spiculisporic acid is 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5. , 2, 3, 4; 5; 6; 7; 8; 9; 10% by weight relative to the total weight of the composition.
Base L’émulsion selon la présente invention comprend au moins une base choisie parmi les acides aminés et les alcanolamines, ladite base étant présente en une quantité apte à former au moins le monosel de l’acide spiculisporique.Base The emulsion according to the present invention comprises at least one base selected from amino acids and alkanolamines, said base being present in an amount capable of forming at least the monosel of spiculisporic acid.
La base utilisée est une base neutralisante, c’est-à-dire qu’elle permet de neutraliser l’acide spiculisporique pour former un sel dudit acide.The base used is a neutralizing base, that is to say it allows to neutralize the spiculisporic acid to form a salt of said acid.
La ou les base(s) est/sont ainsi utililisée(s) en une quantité apte à former le mono-sel, le di-sel, le tri-sel ou un mélange de plusieurs sels d’acide spiculisporique de degrés de salification différents.The base (s) is / are thus used (s) in an amount capable of forming the mono-salt, the di-salt, the tri-salt or a mixture of several salts of spiculisporic acid with different degrees of salification .
Selon un mode de réalisation préféré de l’invention, la quantité de base est choisie de façon à former le monosel de l’acide spiculisporique.According to a preferred embodiment of the invention, the amount of base is chosen so as to form the monosel of spiculisporic acid.
Dans le cadre de l’invention la base est choisie parmi les acides aminés et les alcanolamines.In the context of the invention, the base is chosen from amino acids and alkanolamines.
Plus particulièrement la base peut être choisie parmi les acides aminés basiques suivants l’arginine, la lysine, l’omithine, la citruline et l’histidine. De manière préférée, l’acide aminé est l'arginine.More particularly, the base may be chosen from the basic amino acids arginine, lysine, ornithine, citruline and histidine. Preferably, the amino acid is arginine.
La base peut aussi être choisie parmi les alcanolamines suivantes : les mono-, di- et triéthanolamines, l’isopropanolamine, le 2-amino-2-méthyl-l-propanol, ainsi que leurs mélanges. De manière préférée, l’alcanolamine est la triéthanolamine.The base may also be chosen from the following alkanolamines: mono-, di- and triethanolamines, isopropanolamine, 2-amino-2-methyl-1-propanol, and mixtures thereof. In a preferred manner, the alkanolamine is triethanolamine.
Avantageusement la quantité de base va de 0,1 à 20 %, de préférence de 0,5 à 15 et de manière encore plus préférée de 0,6 à 10 % en poids par rapport au poids total de la composition.Advantageously, the amount of base is from 0.1 to 20%, preferably from 0.5 to 15 and even more preferably from 0.6 to 10% by weight relative to the total weight of the composition.
Milieu physiologiquement acceptablePhysiologically acceptable medium
Outre les composés indiqués précédemment, une composition selon l’invention comprend un milieu physiologiquement acceptable.In addition to the compounds indicated above, a composition according to the invention comprises a physiologically acceptable medium.
Par « milieu physiologiquement acceptable », on entend désigner un milieu convenant particulièrement à l’application d’une composition de l’invention sur la peau et/ou les lèvres, comme l’eau, les huiles ou les solvants organiques couramment employés dans les compositions cosmétiques.By "physiologically acceptable medium" is meant a medium which is particularly suitable for the application of a composition of the invention to the skin and / or the lips, such as water, oils or organic solvents commonly used in the cosmetic compositions.
Le milieu physiologiquement acceptable (tolérance, toxicologie et toucher acceptables) est généralement adapté à la nature du support sur lequel doit être appliquée la composition, ainsi qu’à l’aspect sous lequel la composition doit être conditionnée.The physiologically acceptable medium (tolerability, toxicology and acceptable touch) is generally adapted to the nature of the medium to which the composition is to be applied, as well as to the appearance under which the composition is to be packaged.
Phase grasseFatty phase
La composition conforme à l’invention peut comprendre une phase grasse.The composition according to the invention may comprise a fatty phase.
Comme montré dans les exemples, la composition peut contenir jusqu’à 60 % en poids de phase grasse par rapport au poids total de la composition. Les compositions, même comprenant un taux de phase grasse élevés peuvent conduire à des films stables, homogènes et résistants.As shown in the examples, the composition may contain up to 60% by weight of fatty phase relative to the total weight of the composition. The compositions, even including a high fat phase level can lead to stable, homogeneous and resistant films.
La phase grasse de la composition selon l’invention comprend l’ensemble des composés liposolubles ou lipodispersibles présents dans la composition, et en particulier les corps gras liquides à température ambiante (25 °C) et pression atmosphérique ou huiles (qui forment la phase huileuse).The fatty phase of the composition according to the invention comprises all liposoluble or lipodispersible compounds present in the composition, and in particular liquid fatty substances at ambient temperature (25 ° C.) and atmospheric pressure or oils (which form the oily phase). ).
Les huiles présentes dans la composition conforme à l’invention peuvent être siliconées ou hydrocarbonées.The oils present in the composition according to the invention may be silicone or hydrocarbon-based.
Par huile siliconée (ou huile de silicone), on entend une huile contenant au moins un atome de silicium, et notamment contenant des groupes Si-O.By silicone oil (or silicone oil) is meant an oil containing at least one silicon atom, and in particular containing Si-O groups.
Comme huiles de silicone, on peut citer par exemple les huiles de silicone volatiles comme les cyclopolydiméthylsiloxanes (nom INCI : cyclomethicone), telles que le cyclopentasiloxane, le cyclohexasiloxane, l'octaméthylcyclotétrasiloxane, le décaméthylcyclopentasiloxane, le dodéca-méthylcyclohexasiloxane ; les silicones linéaires telles que rheptaméthylhexyl-trisiloxane, l'heptaméthyloctyl-trisiloxane, l'hexaméthyl-disiloxane, l'octaméthyl-trisiloxane, le décaméthyltétrasiloxane, le dodécaméthyl pentasiloxane ; les huiles de silicone non volatiles comme les polyméthylsiloxanes (PDMS), et les polyméthylsiloxanes phénylés tels que les phényltriméthicônes, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényl-diméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthyl-siloxysilicates, et les polyméthylphénylsiloxanes ; les polysiloxanes modifiés par des acides gras, des alcools gras ou des polyoxyalkylènes, et leurs mélanges.As silicone oils, mention may be made, for example, of volatile silicone oils such as cyclopolydimethylsiloxanes (INCI name: cyclomethicone), such as cyclopentasiloxane, cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodeca-methylcyclohexasiloxane; linear silicones such as rheptamethylhexyl-trisiloxane, heptamethyloctyltrisiloxane, hexamethyl-disiloxane, octamethyl-trisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane; non-volatile silicone oils such as polymethylsiloxanes (PDMS), and phenyl polymethylsiloxanes such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl-dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes; polysiloxanes modified with fatty acids, fatty alcohols or polyoxyalkylenes, and mixtures thereof.
Par « volatile », on entend un composé susceptible de s'évaporer au contact de la peau en moins d'une heure, à température ambiante et pression atmosphérique. L'huile volatile est une huile cosmétique volatile, liquide à température ambiante, ayant notamment une pression de vapeur non nulle, à température ambiante et pression atmosphérique, en particulier ayant une pression de vapeur allant de 0,13 Pa à 40 000 Pa (10-3 à 300 mm de Hg), et de préférence allant de 1,3 Pa à 13 000 Pa (0,01 à 100 mm de Hg), et préférentiellement allant de 1,3 Pa à 1300 Pa (0,01 à 10 mm de Hg).By "volatile" is meant a compound capable of evaporating on contact with the skin in less than one hour, at room temperature and atmospheric pressure. The volatile oil is a volatile cosmetic oil which is liquid at ambient temperature, in particular having a non-zero vapor pressure, at ambient temperature and atmospheric pressure, in particular having a vapor pressure ranging from 0.13 Pa to 40 000 Pa (10 300 mm Hg), and preferably ranging from 1.3 Pa to 13 000 Pa (0.01 to 100 mm Hg), and preferably ranging from 1.3 Pa to 1300 Pa (0.01 to 10 mm Hg), and preferably ranging from 1.3 Pa to 1300 Pa (0.01 to 100 mm Hg), and preferably ranging from 1.3 Pa to 1300 Pa (0.01 to 10 mm Hg), mm Hg).
Par huile hydrocarbonée, on entend une huile formée essentiellement, voire constituée, d’atomes de carbone et d’hydrogène, et éventuellement d'atomes d'oxygène, d'azote, et ne contenant pas d’atome de silicium ou de fluor; elle peut contenir des groupes ester, éther, amine, amide.The term "hydrocarbon-based oil" means an oil formed essentially or even consisting of carbon and hydrogen atoms, and possibly oxygen, nitrogen, and not containing a silicon or fluorine atom; it may contain ester, ether, amine or amide groups.
Comme huiles utilisables dans la composition de l’invention, on peut citer par exemple : - les huiles hydrocarbonées d’origine végétale, telles que le squalane, les triglycérides liquides d’acides gras comportant de 4 à 30 atomes de carbone comme les triglycérides des acides heptanoïque ou octanoïque ou encore, par exemple, les huiles de jojoba, de babassu, de tournesol, d’olive, de noix de coco, de noix du brésil, de marula, de maïs, de soja, de courge, de pépins de raisin, de lin, de sésame, de noisette, d’abricot, de macadamia, d’arara, de coriandre, de ricin, d'avocat, les triglycérides des acides caprylique/caprique comme ceux commercialisés par la société Stearineries Dubois ou ceux commercialisés sous les dénominations Miglyol 810, 812 et 818 par la société Dynamit Nobel, l’huile de beurre de karité ; - les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R1COOR2 et R10R2 dans laquelle RI représente le reste d’un acide gras ou d’un alcool gras comportant de 8 à 29 atomes de carbone, et R2 représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l’huile de Purcellin, le stéarate d’octyl-2-dodécyle, l’érucate d’octyl-2-dodécyle, l’isostéarate d’isostéaryle ; les esters hydroxylés comme l’isostéaryl lactate, l’octylhydroxystéarate, l’hydroxystéarate d’octyldodécyle, le diisostéaryl-malate, le citrate de triisocétyle, les heptanoates, octanoates, décanoates d'alcools gras ; les esters de polyol, comme le dioctanoate de propylène glycol, le diheptanoate de néopentylglycol et le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol comme le tétraisostéarate de pentaérythrytyle ; - les hydrocarbures linéaires ou ramifiés, d’origine minérale ou synthétique, volatils ou non volatils, et leurs dérivés, comme les al canes ramifiés comportant de 8 à 18 atomes de carbone, par exemple les iso-alcanes (appelés aussi isoparaffmes) en C8-C18 comme l'isododécane, l'isodécane, l'isohexadécane, tels que les isoparaffmes vendues sous les noms commerciaux Isopar par la société Exxon Chemical ou les huiles vendues sous les noms commerciaux Permethyl par la société Presperse, l’isohexadécane et l’isododécane commercialisés par la société INEOS ; ainsi que l'huile de vaseline et le polyisobutène hydrogéné tel que l’huile de Parléam® ; les alcanes linéaires volatiles comprenant de 7 à 17 atomes de carbone comme l’undécane, le tridécane ; - les alcools gras liquides à température ambiante ayant de 8 à 26 atomes de carbone, comme l’octyldodécanol, le 2-butyloctanol, le 2-hexyldécanol, le 2-undécylpentadécanol ou l’alcool oléique ; et - leurs mélanges.As oils that can be used in the composition of the invention, mention may be made, for example, of: hydrocarbon-based oils of vegetable origin, such as squalane, liquid triglycerides of fatty acids containing from 4 to 30 carbon atoms, such as triglycerides of heptanoic or octanoic acids or, for example, jojoba, babassu, sunflower, olive, coconut, brazil nut, marula, maize, soya, squash, Grapes, flax, sesame, hazelnut, apricot, macadamia, arara, coriander, castor oil, avocado, triglycerides of caprylic / capric acids such as those marketed by Stearineries Dubois or those marketed under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel, shea butter oil; esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R1COOR2 and R10R2 in which R1 represents the residue of a fatty acid or of a fatty alcohol containing from 8 to 29 carbon atoms, and R2 represents a hydrocarbon chain, branched or unbranched, containing from 3 to 30 carbon atoms, such as, for example, purcellin oil, octyl-2-dodecyl stearate, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythritol tetraisostearate; linear or branched hydrocarbons of mineral or synthetic origin, volatile or non-volatile, and their derivatives, such as branched alkyles containing from 8 to 18 carbon atoms, for example isoalkanes (also called isoparaffms) in C8; -C18 such as isododecane, isodecane, isohexadecane, such as the isoparaffms sold under the trade names Isopar by the company Exxon Chemical or the oils sold under the trade names Permethyl by the company Presperse, the isohexadecane and the isododecane marketed by the company INEOS; as well as petroleum jelly and hydrogenated polyisobutene such as Parleam® oil; volatile linear alkanes comprising 7 to 17 carbon atoms such as undecane, tridecane; fatty alcohols which are liquid at room temperature and have 8 to 26 carbon atoms, such as octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol or oleic alcohol; and - their mixtures.
On peut citer en particulier les huiles suivantes : - les esters issus de la réaction d’au moins un acide gras comportant au moins 6 atomes de carbone, de préférence de 6 à 26 atomes de carbone et mieux de 6 à 20 atomes de carbone, encore mieux de 6 à 16 atomes de carbone et d’au moins un alcool comprenant de 1 à 17 atomes de carbone et mieux de 3 à 15 atomes de carbone ; on peut citer notamment le myristate d’isopropyle, le palmitate d’isopropyle, le caprate/caprylate d’ethyl2-hexyle (ou caprate/caprylate d'octyle), le palmitate d’éthyl-2-hexyle, le néopentanoate d’isostéaryle, l’isononanoate d’isononyle, le laurate d’hexyle, les esters d’acide lactique et d’alcools gras comprenant 12 ou 13 atomes de carbone, le carbonate de dicaprylyle tel que celui qui est commercialisé sous la dénomination CETIOL CC par la société COGNIS, - les éthers d’acide gras comprenant de 6 à 20 atomes de carbone tel que le dicaprylyl éther (Cetiol OE de Cognis), - les éthers de glycérol comprenant de 6 à 12 atomes de carbone comme le 2-éthyl hexyle éther de glycérol (nom INCI : ethylhexylglycerin) tel que le Sensiva SC 50 de la société Schulke & Mayr GmbH ; - l’octydodécanol, - les alcanes tels que ceux qui sont décrits dans les demandes de brevets de la société Cognis WO 2007/068371, ou WO2008/155059 (mélanges d’alcanes distincts et différant d’au moins un carbone). Ces alcanes sont obtenus à partir d’alcools gras, eux-mêmes obtenus à partir d’huile de coprah ou de palme. A titre d’exemple d’alcanes linéaires convenant à l’invention, on peut citer le n- heptane (C7), le n-octane (C8), le n-nonane (C9), le n-décane (CIO), le n-undécane (Cil), le n-dodécane (C12), le n-tridécane (C13), le n-tétradecane (C14), et leurs mélanges. Selon un mode de réalisation particulier, l’alcane linéaire volatil est choisi parmi le n-nonane, le n-undécane, le n-dodécane, le n-tridécane, le n-tétradécane, et leurs mélanges.Mention may in particular be made of the following oils: esters derived from the reaction of at least one fatty acid comprising at least 6 carbon atoms, preferably from 6 to 26 carbon atoms and better still from 6 to 20 carbon atoms, more preferably from 6 to 16 carbon atoms and from at least one alcohol comprising from 1 to 17 carbon atoms and more preferably from 3 to 15 carbon atoms; mention may be made in particular of isopropyl myristate, isopropyl palmitate, ethyl 2-hexyl caprate / caprylate (or octyl caprate / caprylate), 2-ethylhexyl palmitate, isostearyl neopentanoate isononyl isononanoate, hexyl laurate, esters of lactic acid and of fatty alcohols comprising 12 or 13 carbon atoms, dicaprylyl carbonate, such as that marketed under the name CETIOL CC by COGNIS company, - fatty acid ethers comprising from 6 to 20 carbon atoms such as dicaprylyl ether (Cetiol OE de Cognis), - glycerol ethers comprising from 6 to 12 carbon atoms such as 2-ethyl hexyl ether glycerol (INCI name: ethylhexylglycerin) such as Sensiva SC 50 from Schulke & Mayr GmbH; octydodecanol, alkanes such as those described in the patent applications of Cognis WO 2007/068371, or WO2008 / 155059 (mixtures of distinct alkanes and differing from at least one carbon). These alkanes are obtained from fatty alcohols, themselves obtained from coconut oil or palm oil. By way of example of linear alkanes which are suitable for the invention, mention may be made of n-heptane (C7), n-octane (C8), n-nonane (C9), n-decane (C10), n-undecane (Cil), n-dodecane (C12), n-tridecane (C13), n-tetradecane (C14), and mixtures thereof. According to a particular embodiment, the volatile linear alkane is selected from n-nonane, n-undecane, n-dodecane, n-tridecane, n-tetradecane, and mixtures thereof.
Selon un mode préféré, on peut citer les mélanges de n-undécane (Cil) et de n-tridécane (Cl3) obtenus aux exemples 1 et 2 de la demande W02008/155059 de la Société Cognis ; - les polyesters obtenus par condensation de dimère et/ou trimère d’acide gras insaturé et de diol comme par exemple les polyesters d’acide dilinoléique et de diol commercialisés par Biosynthis sous la dénomination Viseoplast et notamment le polymère portant le nom MCI dilinoleic acid/propanediol copolymer ; et » leurs mélanges.According to a preferred embodiment, mention may be made of the mixtures of n-undecane (Cil) and n-tridecane (Cl 3) obtained in Examples 1 and 2 of Application WO2008 / 155059 from Cognis; the polyesters obtained by condensation of dimer and / or trimer of unsaturated fatty acid and of diol, for instance the polyesters of dilinoleic acid and of diol marketed by Biosynthis under the name Viseoplast and in particular the polymer bearing the name MCI dilinoleic acid / propanediol copolymer; and »their mixtures.
De préférence, l’huile est choisie parmi les huiles végétales telles que citées ci- dessus.Preferably, the oil is chosen from vegetable oils as mentioned above.
La quantité de phase passe dans la composition de l’invention peut aller de 0,1 % à 70 % en poids, de préférence de 1 à 70 %, mieux de 5 % à 60 % en poids par rapport au poids total de la composition.The amount of phase in the composition of the invention may range from 0.1% to 70% by weight, preferably from 1 to 70%, more preferably from 5% to 60% by weight relative to the total weight of the composition. .
Phase aqueuse L’eau peut être présente en une teneur totale allant de de 30 à 90%, de préférence 40 à 85 % en poids, par rapport au poids total de la composition.Aqueous phase Water may be present in a total content ranging from 30 to 90%, preferably 40 to 85% by weight, relative to the total weight of the composition.
De façon préférée, la composition selon l’invention comprend au moins 30 %, de préférence au moins 40 % en poids d’eau, de préférence au moins 50 % en poids d’eau, par rapport au poids total de la composition.Preferably, the composition according to the invention comprises at least 30%, preferably at least 40% by weight of water, preferably at least 50% by weight of water, relative to the total weight of the composition.
La composition conforme à l’invention peut comprendre outre denl’eau, au moins un solvant hydrosoluble.The composition according to the invention may comprise, besides water, at least one water-soluble solvent.
La phase aqueuse constitue la phase continue de la composition.The aqueous phase constitutes the continuous phase of the composition.
Par composition à phase continue aqueuse, on entend que la composition présente une conductivité, mesurée à 25 °C, supérieure ou égale à 23 pS/em (mieroSiemens/cm), la conductivité étant mesurée par exemple à l’aide d’un conductimètre MPC227 de Mettler Toledo et d’une cellule de mesure de conductivité Inlab730. La cellule de mesure est immergée dans la composition, de façon à éliminer les bulles d'air susceptibles de se former entre les 2 électrodes de la cellule, La lecture de la conductivité est faite dès que la valeur du conductimètre est stabilisée. Une moyenne est réalisée sur au moins 3 mesures successives.By aqueous continuous phase composition, it is meant that the composition has a conductivity, measured at 25 ° C., of greater than or equal to 23 μS / em (mm.siemens / cm), the conductivity being measured for example using a conductivity meter. MPC227 from Mettler Toledo and an Inlab730 conductivity cell. The measuring cell is immersed in the composition, so as to eliminate any air bubbles that may form between the 2 electrodes of the cell. The reading of the conductivity is made as soon as the value of the conductivity meter is stabilized. An average is performed on at least 3 successive measurements.
Par « solvant hydrosoluble », on désigne dans la présente invention un composé liquide à température ambiante et miscible à l’eau (miscibilité dans l’eau supérieure à 50 % en poids à 25 °C et pression atmosphérique).By "water-soluble solvent" is meant in the present invention a liquid compound at room temperature and miscible with water (miscibility in water greater than 50% by weight at 25 ° C and atmospheric pressure).
Les solvants hydrosolubles utilisables dans les compositions selon rinvention peuvent en outre être volatils.The water-soluble solvents which can be used in the compositions according to the invention can moreover be volatile.
Parmi les solvants hydrosolubles pouvant être utilisés dans les compositions conformes à l’invention, on peut citer notamment les monoalcools inférieurs ayant de 1 à 5 atomes de carbone tels que l’éthanol et l’isopropanol.Among the water-soluble solvents that can be used in the compositions in accordance with the invention, there may be mentioned lower monoalcohols having from 1 to 5 carbon atoms such as ethanol and isopropanol.
Dans la présente invention, par « polyol » on entend les glycols ayant de 2 à 8 atomes de carbone tels que l’éthylène glycol, le propylène glycol, le 1,3-butylène glycol et le dipropylène glycol, les cétones en C3 et C4 et les aldéhydes en C2-C4, ou les polyols tels que par exemple la glycérine.In the present invention, the term "polyol" means glycols having from 2 to 8 carbon atoms, such as ethylene glycol, propylene glycol, 1,3-butylene glycol and dipropylene glycol, and C3 and C4 ketones. and C2-C4 aldehydes, or polyols such as, for example, glycerine.
Comme déjà mentionné, la composition selon l’invention comprend moins de 3 %, de préférence moins de 1 % en poids de glycol(s) ou de polyol(s) par rapport au poids total de la composition. Avantageusement la composition selon l’invention est dénuée de glycol(s) et/ou de polyol(s).As already mentioned, the composition according to the invention comprises less than 3%, preferably less than 1% by weight of glycol (s) or polyol (s) relative to the total weight of the composition. Advantageously, the composition according to the invention is devoid of glycol (s) and / or polyol (s).
Avantageusement le ratio glycol(s)/acide spiculisporique ou polyol(s)/acide spiculisporique est inférieur à 1, de préférence inférieur à 0,2.Advantageously, the ratio glycol (s) / spiculisporic acid or polyol (s) / spiculisporic acid is less than 1, preferably less than 0.2.
La phase aqueuse (eau et éventuellement le solvant miscible à l'eau) peut être présente dans la composition en une teneur allant de 0,1 % à 99,9 % en poids, par rapport au poids total de la composition, de préférence allant de 40 % à 95 % en poids.The aqueous phase (water and optionally the solvent miscible with water) may be present in the composition in a content ranging from 0.1% to 99.9% by weight, relative to the total weight of the composition, preferably ranging from from 40% to 95% by weight.
Agent épaississantThickening agent
Une composition selon l’invention peut comprendre au moins un agent gélifiant hydrophile en tant qu’épaississant.A composition according to the invention may comprise at least one hydrophilic gelling agent as a thickener.
De préférence les gélifiants hydrophiles sont polymériques et avantageusement ils sont naturels ou d’origine naturelle.Preferably, the hydrophilic gelling agents are polymeric and advantageously they are natural or of natural origin.
Au sens de l’invention, l’expression « d’origine naturelle » entend désigner les gélifiants polymériques obtenus par modification des gélifiants polymériques naturels.For the purposes of the invention, the expression "of natural origin" means polymeric gelling agents obtained by modifying natural polymeric gelling agents.
Ces gélifiants peuvent être particulaires ou non particulaires.These gelling agents may be particulate or non-particulate.
Plus précisément, ces gélifiants relèvent de la catégorie des polysaccharides.More specifically, these gelling agents fall within the category of polysaccharides.
De manière avantageuse, les polysaccharides peuvent être choisis parmi les carraghénanes, en particulier la kappa-carraghenane, la gomme de gellane, l’agar-agar, la gomme de xanthane, les composés à base d’alginate, en particulier l’alginate de sodium, la gomme de scéroglucane, la gomme de guar, l’inuline, le pullulan, et leurs mélanges.Advantageously, the polysaccharides may be chosen from carrageenans, in particular kappa-carrageenan, gellan gum, agar-agar, xanthan gum, and alginate-based compounds, in particular alginate. sodium, saroglucan gum, guar gum, inulin, pullulan, and mixtures thereof.
De manière préférée, le gélifiant hydrophile est la gomme de xanthane.Preferably, the hydrophilic gelling agent is xanthan gum.
En fonction de l’application visée, une composition selon l’invention peut comprendre en outre une ou plusieurs charge(s) classiquement utilisée(s) dans les compositions notamment de soin et/ou de maquillage, des matières colorantes notamment des pigments, des nacres, des particules à reflet métallique.Depending on the intended application, a composition according to the invention may also comprise one or more filler (s) conventionally used in the care and / or make-up compositions, dyestuffs, in particular pigments, nacres, particles with a metallic sheen.
Un avantage de la présente invention est qu’elle permet une dispersion homogène de ces charges, nacres, pigments dans la composition.An advantage of the present invention is that it allows a homogeneous dispersion of these fillers, nacres, pigments in the composition.
Bien entendu l’homme du métier choisira ces additifs de manière à ce qu’ils soient compatibles avec les autres composants de la composition.Of course those skilled in the art will choose these additives so that they are compatible with the other components of the composition.
ChargeCharge
Une composition selon l’invention peut comprendre en outre une ou plusieurs charge(s) classiquement utilisée(s) dans les compositions notamment de soin et/ou de maquillage et différentes des pigments, nacres, particules à reflet métallique.A composition according to the invention may furthermore comprise one or more filler (s) conventionally used in the care and / or make-up compositions, and various of the pigments, nacres and particles with a metallic sheen.
Ces charges sont des particules incolores ou blanches, solides de toutes formes, qui se présentent sous une forme insoluble et dispersée dans le milieu de la composition.These fillers are colorless or solid white particles of all shapes, which are in an insoluble form and dispersed in the medium of the composition.
De nature minérale ou organique, naturelle ou synthétique, elles permettent de conférer à la composition les contenant de la douceur, de la matité et de l’uniformité au maquillage. En outre, ces charges permettent avantageusement de lutter contre différentes agressions telles que le sébum ou la sueur. A titre illustratif de ces charges, peuvent être cités le talc, le mica, la silice, le kaolin, les poudres de ροΐγ-β-alanine et de polyéthylène, les poudres de polymères de tétrafluoroéthylène (Téflon®), la lauroyl-lysine, l'amidon, le nitrure de bore, les microsphères creuses polymériques telles que celles de chlorure de polyvinylidène/acrylonitrile comme l'Expancel® (Nobel industrie), de copolymères d'acide acrylique, les microbilles de résine de silicone (Tospearls® de Toshiba, par exemple), les particules de polyorganosiloxanes élastomères, le carbonate de calcium précipité, le carbonate et l’hydro-carbonate de magnésium, l’hydroxyapatite, le sulfate de barium, les poudres de polyuréthane, les charges composites, les microsphères de silice creuses, et les microcapsules de verre ou de céramique. On peut également utiliser des particules, qui ont la forme de portions de sphères creuses, telles que décrites dans les demandes de brevet JP-2003 128 788 et JP-2000 191 789.Of mineral or organic nature, natural or synthetic, they make it possible to confer on the composition containing them softness, dullness and uniformity in makeup. In addition, these fillers advantageously make it possible to fight against various aggressions such as sebum or sweat. As an illustration of these fillers, mention may be made of talc, mica, silica, kaolin, ροΐγ-β-alanine and polyethylene powders, tetrafluoroethylene polymer powders (Teflon®), lauroyl-lysine, starch, boron nitride, polymeric hollow microspheres such as those of polyvinylidene chloride / acrylonitrile such as Expancel® (Nobel industry), acrylic acid copolymers, silicone resin microbeads (Toshiba Tospearls®) for example), elastomeric polyorganosiloxane particles, precipitated calcium carbonate, magnesium carbonate and hydrocyanate, hydroxyapatite, barium sulfate, polyurethane powders, composite fillers, silica microspheres hollow, and microcapsules of glass or ceramic. It is also possible to use particles, which are in the form of portions of hollow spheres, as described in patent applications JP-2003 128 788 and JP-2000 191 789.
En particulier, de telles charges peuvent être présentes dans une composition selon l’invention dans une teneur comprise entre 0.01 % et 25 % en poids, notamment comprise entre 0.1 % et 20 % en poids, en particulier comprise entre 1 % et 10 %, poids, par rapport au poids total de la compositionIn particular, such fillers may be present in a composition according to the invention in a content of between 0.01% and 25% by weight, in particular between 0.1% and 20% by weight, in particular between 1% and 10%, weight, relative to the total weight of the composition
Nacresnacres
La composition selon l’invention peut également comprendre au moins une nacre.The composition according to the invention may also comprise at least one mother-of-pearl.
Par « nacres », il faut comprendre des particules colorées de toute forme, irisées ou non, notamment produites par certains mollusques dans leur coquille ou bien synthétisées, et qui présentent un effet de couleur par interférence optique.By "nacres", it is necessary to include colored particles of any shape, iridescent or not, in particular produced by certain shellfish in their shell or else synthesized, and which exhibit a color effect by optical interference.
Une composition selon l’invention peut comprendre de 0 % à 15 % en poids de nacres, par rapport au poids total de ladite composition.A composition according to the invention may comprise from 0% to 15% by weight of nacres, relative to the total weight of said composition.
Les nacres peuvent être choisies parmi les pigments nacrés, tels que le mica titane recouvert avec un oxyde de fer, le mica titane recouvert avec de l’oxychlorure de bismuth, le mica titane recouvert avec de l’oxyde de chrome, le mica titane recouvert avec un colorant organique, ainsi que les pigments nacrés à base d’oxychlorure de bismuth. Il peut également s’agir de particules de mica à la surface desquelles sont superposées au moins deux couches successives d’oxydes métalliques et/ou de matières colorantes organiques.The nacres can be chosen from pearlescent pigments, such as titanium mica coated with an iron oxide, titanium mica coated with bismuth oxychloride, titanium mica coated with chromium oxide, titanium mica coated with with an organic dye, as well as pearlescent pigments based on bismuth oxychloride. It may also be mica particles on the surface of which are superimposed at least two successive layers of metal oxides and / or organic dyestuffs.
On peut également citer, à titre d’exemple de nacres, le mica naturel recouvert d’oxyde de titane, d’oxyde de fer, de pigment naturel ou d’oxychlorure de bismuth.Mention may also be made, by way of example of nacres, of natural mica coated with titanium oxide, with iron oxide, with natural pigment or with bismuth oxychloride.
Parmi les nacres disponibles sur le marché, on peut citer les nacres Timica, Flamenco et Duochrome (sur base de mica) commercialisées par la société ENGELHARD, les nacres Timiron commercialisées par la société Merck, les nacres sur base de mica Prestige commercialisées par la société Eckart et les nacres sur base de mica synthétique Sunshine commercialisées par la société Sun Chemical.Among the nacres available on the market, mention may be made of the nacres Timica, Flamenco and Duochrome (based on mica) marketed by ENGELHARD, the nacres Timiron marketed by Merck, nacres based on mica Prestige marketed by the company Eckart and nacres based on Sunshine synthetic mica sold by the company Sun Chemical.
Les nacres peuvent plus particulièrement posséder une couleur ou un reflet jaune, rose, rouge, bronze, orangé, brun, or et/ou cuivré.The nacres may more particularly have a color or a yellow, pink, red, bronze, orange, brown, gold and / or coppery reflection.
De manière avantageuse, les nacres conformes à l’invention sont les micas recouverts de dioxyde de titane ou d’oxyde de fer ainsi que l’oxychlorure de bismuth.Advantageously, the nacres according to the invention are micas coated with titanium dioxide or iron oxide and bismuth oxychloride.
Pigmentspigments
Comme énoncé précédemment, une composition peut contenir en outre des pigments.As stated above, a composition may further contain pigments.
Ces pigments peuvent être des pigments minéraux notamment tel que définis précédemment.These pigments may be inorganic pigments in particular as defined above.
Ces pigments peuvent être également des pigments organiques.These pigments can also be organic pigments.
Par « pigment organique », on entend tout pigment qui répond à la définition de l’encyclopédie Ullmann dans le chapitre pigment organique. Le pigment organique peut notamment être choisi parmi les composés nitroso, nitro, azo, xanthène, quinoléine, anthraquinone, phtalocyanine, de type complexe métallique, isoindolinone, isoindoline, quinacridone, périnone, pérylène, dicétopyrrolopyrrole, thioindigo, dioxazine, triphénylméthane, quinophtalone.By "organic pigment" is meant any pigment that meets the definition of the Ullmann encyclopedia in the organic pigment chapter. The organic pigment may especially be chosen from nitroso compounds, nitro, azo, xanthene, quinoline, anthraquinone, phthalocyanine, metal complex type, isoindolinone, isoindoline, quinacridone, perinone, perylene, diketopyrrolopyrrole, thioindigo, dioxazine, triphenylmethane, quinophthalone.
Le ou les pigments organiques peuvent être choisis par exemple parmi le carmin, le noir de carbone, le noir d’aniline, la mélanine, le jaune azo, la quinacridone, le bleu de phtalocyanine, le rouge sorgho, les pigments bleus codifiés dans le Color Index sous les références CI 42090, 69800, 69825, 73000, 74100, 74160, les pigments jaunes codifiés dans le Color Index sous les références CI 11680, 11710, 15985, 19140, 20040, 21100, 21108, 47000, 47005, les pigments verts codifiés dans le Color Index sous les références CI 61565, 61570, 74260, les pigments oranges codifiés dans le Color Index sous les références CI 11725, 15510, 45370, 71105, les pigments rouges codifiés dans le Color Index sous les références CI 12085, 12120, 12370, 12420, 12490, 14700, 15525, 15580, 15620, 15630, 15800, 15850, 15865, 15880, 17200, 26100, 45380, 45410, 58000, 73360, 73915, 75470, et les pigments obtenus par polymérisation oxydante de dérivés indoliques, phénoliques tels qu’ils sont décrits dans le brevet FR 2 679 771.The organic pigment (s) may be chosen, for example, from carmine, carbon black, aniline black, melanine, azo yellow, quinacridone, phthalocyanine blue, sorghum red, and blue pigments codified in the formula. Color Index under the references CI 42090, 69800, 69825, 73000, 74100, 74160, the yellow pigments coded in the Color Index under the references CI 11680, 11710, 15985, 19140, 20040, 21100, 21108, 47000, 47005, the pigments coded in the Color Index under the references CI 61565, 61570, 74260, the orange pigments coded in the Color Index under the references CI 11725, 15510, 45370, 71105, the red pigments codified in the Color Index under the references CI 12085, 12120, 12370, 12420, 12490, 14700, 15525, 15580, 15620, 15630, 15800, 15850, 15865, 15880, 17200, 26100, 45380, 45410, 58000, 73360, 73915, 75470, and the pigments obtained by oxidative polymerization of indole derivatives, phenolic as they are t described in patent FR 2 679 771.
Ces pigments peuvent aussi être sous forme de pigments composites tels qu’ils sont décrits dans le brevet EP 1 184 426. Ces pigments composites peuvent être composés notamment de particules comportant un noyau inorganique recouvert au moins partiellement d’un pigment organique et au moins un liant assurant la fixation des pigments organiques sur le noyau.These pigments can also be in the form of composite pigments as described in patent EP 1 184 426. These composite pigments can be composed in particular of particles comprising an inorganic core at least partially covered with an organic pigment and at least one binder ensuring the fixation of organic pigments on the core.
Le pigment peut aussi être une laque. Par laque, on entend les colorants insolubilisés adsorbés sur des particules insolubles, l’ensemble ainsi obtenu restant insoluble lors de l’utilisation.The pigment can also be a lacquer. By lacquer is meant insolubilized dyes adsorbed on insoluble particles, the assembly thus obtained remaining insoluble during use.
Les substrats inorganiques sur lesquels sont adsorbés les colorants sont par exemple l’alumine, la silice, le borosilicate de calcium et de sodium ou le borosilicate de calcium et d’aluminium, et l’aluminium.The inorganic substrates on which the dyes are adsorbed are, for example, alumina, silica, calcium and sodium borosilicate or calcium and aluminum borosilicate, and aluminum.
Parmi les colorants organiques, on peut citer le carmin de cochenille. On peut également citer les produits connus sous les dénominations suivantes : D&C Red 21 (CI 45 380), D&C Orange 5 (CI 45 370), D&C Red 27 (CI 45 410), D&C Orange 10 (CI 45 425), D&C Red 3 (CI 45 430), D&C Red 4 (CI 15 510), D&C Red 33 (CI 17 200), D&C Yellow 5 (CI 19 140), D&C Yellow 6 (CI 15 985), D&C Green (CI 61 570), D&C Yellow 1 O (CI 77 002), D&C Green 3 (CI 42 053), D&C Blue 1 (CI 42 090). A titre d’exemples de laques, on peut citer le produit connu sous la dénomination D&C Red 7 (CI 15 850:1).Among the organic dyes, mention may be made of cochineal carmine. Mention may also be made of the products known under the following names: D & C Red 21 (CI 45,380), D & C Orange 5 (CI 45,370), D & C Red 27 (CI 45,410), D & C Orange 10 (CI 45,425), D & C Red 3 (CI 45,430), D & C Red 4 (CI 15,510), D & C Red 33 (CI 17,200), D & C Yellow 5 (CI 19,140), D & C Yellow 6 (CI 15,985), D & C Green (CI 61,570), D & C Yellow 10 (CI 77,002), D & C Green 3 (CI 42,053), D & C Blue 1 ( CI 42,090). As examples of lacquers, mention may be made of the product known under the name D & C Red 7 (CI 15 850: 1).
Avantageusement, une composition selon l’invention peut comprendre au moins un filtre UV.Advantageously, a composition according to the invention may comprise at least one UV filter.
Filtre ÜVÜV filter
Ce filtre est choisi parmi les filtres UV-A et/ou UV-B.This filter is chosen from UV-A and / or UV-B filters.
Encore plus particulièrement, ledit filtre UV est choisi parmi les filtres UV organiques hydrosolubles, les filtres organiques liposolubles et leurs mélanges et plus particulièrement les filtres UV organiques liposolubles. A titre d’illustration des filtres UV et de façon non limitative, on peut citer les anthranilates, en particulier l’anthranilate de menthyle ; les benzophénones, en particulier la benzophénone-1, la benzophénone-3, la benzophénone-5, la benzophénone-6, la benzophénone-8, la benzophénone-9, la benzophénone-12, et préférentiellement la Benzophénone-2 (Oxybenzone), ou la Benzophénone-4 (Uvinul MS40® disponible chez B.A S.F.) ; les benzylidènes-camphres, en particulier le 3-benzylidène-camphre, l’acide benzylidènecampho-sulfonique, le benzalkoniumméthosulfate de Camphre, le polyacrylamidométhylbenzylidène camphre, l’acide téréphthalylidène di-camphre sulfonique, et préférentiellement le 4-méthylbenzylidène camphre (Eusolex 6300® disponible chez Merck) ; les benzimidazoles, en particulier le benzimidazilate (Neo Heliopan AP® disponible chez Haarmann et Reimer), ou l’acide phénylbenzimidazole sulfonique (Eusolex 232® disponible chez Merck) ; les benzotriazoles, en particulier le drométrizole trisiloxane, ou le méthylène bis-benzotriazolyltétraméthylbutylphénol (Tinosorb M® disponible chez Ciba) ; les cinnamates, en particulier le cinoxate, le DEA méthoxycinnamate, le méthylcinnamate de diisopropyle, le glycéryl éthylhexanoate de diméthoxycinnamate, le méthoxycinnamate d’isopropyle, le cinnamate d’isoamyle, et préférentiellement l’éthocrylène (UvinulN35® disponible chez B.A.S.F.), l’octylméthoxycinnamate (Parsol MCX® disponible chez Hoffmann La Roche), ou l’octocrylène (Uvinul 539® disponible chez B.A.S.F.) ; les dibenzoylméthanes, en particulier le butyl méthoxydibenzoylméthane (Parsol 1789®) ; les imidazolines, en particulier l’éthylhexyl diméthoxybenzylidène dioxoimidazoline ; les PABA, en particulier l’éthyl Dihydroxypropyl PABA, réthylhexyldiméthyl PABA, le glycéryl PABA, le PABA, le PEG-25 PABA, et préférentiellement la diéthylhexylbutamido-triazone (Uvasorb HEB® disponible chez 3V Sigma), réthylhexyltriazone (Uvinul T150® disponible chez B.A.S.F.), ou l’éthyl PABA (benzocaïne) ; le Mexoryl® ; les salicylates, en particulier le salicyclate de dipropylèneglycol, le salicylate d’éthylhexyle, l’homosalate, ou le TEA salicylate ; les triazines, en particulier l’anisotriazine (Tinosorb S® disponible chez Ciba) ; le drometrizole trisiloxane, l'oxyde de zinc, le dioxyde de titane, l’oxyde de zinc, de fer, de zirconium, de cérium enrobés ou non.Even more particularly, said UV filter is chosen from water-soluble organic UV filters, liposoluble organic filters and their mixtures, and more particularly liposoluble organic UV filters. By way of illustration of the UV filters, and in a nonlimiting manner, mention may be made of anthranilates, in particular menthyl anthranilate; benzophenones, in particular benzophenone-1, benzophenone-3, benzophenone-5, benzophenone-6, benzophenone-8, benzophenone-9, benzophenone-12, and preferentially benzophenone-2 (oxybenzone), or Benzophenone-4 (Uvinul MS40® available from BA SF); benzylidenecamphers, in particular 3-benzylidene camphor, benzylidenecamphosulfonic acid, camphor benzalkonium methosulphate, polyacrylamidomethylbenzylidene camphor, terephthalylidene di-camphorsulfonic acid, and preferentially 4-methylbenzylidene camphor (Eusolex 6300®). available from Merck); benzimidazoles, in particular benzimidazilate (Neo Heliopan AP® available from Haarmann and Reimer), or phenylbenzimidazole sulfonic acid (Eusolex 232® available from Merck); benzotriazoles, in particular trisiloxane drometzol, or methylene bis-benzotriazolyltetramethylbutylphenol (Tinosorb M® available from Ciba); cinnamates, in particular cinoxate, DEA methoxycinnamate, diisopropyl methylcinnamate, dimethoxycinnamate glyceryl ethylhexanoate, isopropyl methoxycinnamate, isoamyl cinnamate, and preferably ethocrylene (UvinulN35® available from BASF), octyl methoxycinnamate (Parsol MCX® available from Hoffmann La Roche), or octocrylene (Uvinul 539® available from BASF); dibenzoylmethanes, in particular butyl methoxydibenzoylmethane (Parsol 1789®); imidazolines, in particular ethylhexyl dimethoxybenzylidene dioxoimidazoline; PABAs, in particular ethyl dihydroxypropyl PABA, ethylhexyldimethyl PABA, glyceryl PABA, PABA, PEG-25 PABA, and preferentially diethylhexylbutamido-triazone (Uvasorb HEB® available from 3V Sigma), ethylhexyltriazone (Uvinul T150® available from BASF), or ethyl PABA (benzocaine); Mexoryl®; salicylates, especially dipropylene glycol salicyclate, ethylhexyl salicylate, homosalate, or TEA salicylate; triazines, in particular anisotriazine (Tinosorb S® available from Ciba); trisiloxane drometrizole, zinc oxide, titanium dioxide, zinc oxide, iron oxide, zirconium oxide, cerium oxide coated or uncoated.
Dans un mode de réalisation préféré, la présence d’acide spiculisporique dans les compositions selon l’invention comprenant des filtres de protection solaire résulte en une augmentation surprenante du SPF par rapport à des compositions équivalentes ne comprenant pas d’acide spiculisporique.In a preferred embodiment, the presence of spiculisporic acid in the compositions according to the invention comprising sun protection filters results in a surprising increase in SPF compared to equivalent compositions not comprising spiculisporic acid.
Agent dispersant additionnelAdditional dispersing agent
Avantageusement, une composition selon l’invention peut comprendre en outre un agent dispersant additionnel.Advantageously, a composition according to the invention may further comprise an additional dispersing agent.
Un tel agent dispersant peut être un tensioactif, un oligomère, un polymère ou un mélange de plusieurs d’entre eux.Such a dispersing agent may be a surfactant, an oligomer, a polymer or a mixture of several of them.
Selon un mode de réalisation particulier, un agent dispersant conforme à l’invention est un tensioactif.According to a particular embodiment, a dispersing agent according to the invention is a surfactant.
ActifActive
Selon un mode de réalisation particulier, la composition selon l’invention peut en outre comprendre au moins un actif additionnel choisi parmi les tensioactifs additionnels, les agents hydratants, les agents anti-rides ou anti-âge, les agents desquamants, les agents antioxydants, les actifs stimulants la synthèse des macromolécules dermiques et/ou épidermiques, les agents dermodécontractants, les agents dépigmentants, les agents déodorants, les parfums et leurs mélanges.According to a particular embodiment, the composition according to the invention may further comprise at least one additional active agent chosen from additional surfactants, moisturizing agents, anti-wrinkle or anti-aging agents, desquamating agents, antioxidants, stimulating active ingredients synthesis of dermal and / or epidermal macromolecules, dermodecontracting agents, depigmenting agents, deodorants, perfumes and mixtures thereof.
Ces actifs additionnels peuvent être présents dans la composition selon l’invention en une teneur allant de 0,001 % à 30 % en poids, de préférence de 0,01 % à 20 % en poids, et plus préférentiellement de 0,1 % à 15 % en poids, par rapport au poids total de la composition les comprenant.These additional active agents may be present in the composition according to the invention in a content ranging from 0.001% to 30% by weight, preferably from 0.01% to 20% by weight, and more preferably from 0.1% to 15% by weight. by weight, relative to the total weight of the composition comprising them.
Agents anti-rides ou anti-âge A titre représentatif d’agents anti-rides ou anti-âge utilisables dans la présente invention peuvent plus particulièrement être mentionnés l’adénosine, le rétinol et ses dérivés, l'acide ascorbique et ses dérivés, tels que l'ascorbyl phosphate de magnésium et le glucoside d'ascorbyle ; le tocophérol et ses dérivés, tels que l'acétate de tocophéryle ; l'acide nicotinique et ses précurseurs, tels que la nicotinamide ; l'ubiquinone ; le glutathion et ses précurseurs, tels que l'acide L-2-oxothiazolidine-4-carboxylique ; les composés C-glycoside et leurs dérivés, tels que décrits notamment ci-après ; les extraits de plantes et notamment les extraits de criste marine et de feuille d'olivier, ainsi que les protéines végétales et leurs hydrolysats, tels que les hydrolysats de protéines de riz ou de soja ; ou encore les extraits de graines de Vigna aconitifolia comme ceux commercialisés par la société Cognis sous les références Vitoptine LS9529 et Vit-A-Like LS9737 ; les extraits d'algues et en particulier de laminaires ; les extraits bactériens ; les sapogénines, telles que la diosgénine et les extraits de Dioscorées, en particulier de Wild Yam, en contenant ; les α-hydroxyacides ; les β-hydroxyacides, tels que l'acide salicylique et l'acide n-octanoyl-5-salicylique ; les oligopeptides et pseudodipeptides et leurs dérivés acylés, en particulier l'acide {2-[acetyl-(3-trifluoromethyl-phenyl)-amino]-3-methyl-butyrylamino} acétique et les lipopeptides commercialisés par la société SEDERMA sous les dénominations commerciales Matrixyl 500 et Matrixyl 3000 ; le lycopène ; les sels de manganèse et de magnésium, en particulier les gluconates ; et leurs mélanges.Anti-wrinkle or anti-aging agents Representative of anti-wrinkle or anti-aging agents that may be used in the present invention may more particularly be mentioned adenosine, retinol and its derivatives, ascorbic acid and its derivatives, such as that magnesium ascorbyl phosphate and ascorbyl glucoside; tocopherol and its derivatives, such as tocopheryl acetate; nicotinic acid and its precursors, such as nicotinamide; ubiquinone; glutathione and its precursors, such as L-2-oxothiazolidine-4-carboxylic acid; C-glycoside compounds and their derivatives, as described in particular below; plant extracts and in particular extracts of sea fennel and olive leaf, as well as vegetable proteins and their hydrolysates, such as hydrolysates of rice or soy proteins; or Vigna aconitifolia seed extracts such as those marketed by Cognis under the references Vitoptine LS9529 and Vit-A-Like LS9737; algae extracts and in particular laminaria; bacterial extracts; sapogenins, such as diosgenin and extracts of Dioscorea, in particular Wild Yam, containing it; α-hydroxy acids; β-hydroxyacids, such as salicylic acid and n-octanoyl-5-salicylic acid; oligopeptides and pseudodipeptides and their acylated derivatives, in particular {2- [acetyl- (3-trifluoromethyl-phenyl) -amino] -3-methyl-butyrylamino} acetic acid and lipopeptides marketed by SEDERMA under the trade names Matrixyl 500 and Matrixyl 3000; lycopene; manganese and magnesium salts, in particular gluconates; and their mixtures.
Agents humectants ou hydratantsHumectants or moisturizers
Comme agents humectants ou hydratants, on peut citer notamment un extrait d’aloe vera, l’urée et ses dérivés notamment l’Hydrovance® commercialisée par National Starch, des monosaccharides comme le mannose, l’acide hyaluronique, les AHA, les BHA, des homopolymères d’acide acrylique comme le Lipidure-HM® de NOF corporation, le beta-glucan et en particulier le sodium carboxymethyl beta-glucane de Mibelle-AG-Biochemistry ; un polyoxybutylène polyoxyéthylène polyoxypropylène glycérol comme le WILBRIDE S-753L® de NOF corporation, une huile de rosier muscat commercialisée par Nestlé ; des sphères de collagène et de chondroïtine sulfate d’origine marine (Ateocollagen) commercialisées par la société Engelhard Lyon sous la dénomination sphères de comblement marines ; des sphères d’acide hyaluronique telles que celles commercialisées par la société Engelhard Lyon.As humectants or moisturizers, mention may be made in particular of aloe vera extract, urea and its derivatives, in particular Hydrovance® marketed by National Starch, monosaccharides such as mannose, hyaluronic acid, AHAs and BHAs, homopolymers of acrylic acid such as Lipidure-HM® from NOF corporation, beta-glucan and in particular sodium carboxymethyl beta-glucan from Mibelle-AG-Biochemistry; a polyoxybutylene polyoxyethylene polyoxypropylene glycerol such as WILBRIDE S-753L® from NOF corporation, a muscat rose oil marketed by Nestlé; spheres of collagen and chondroitin sulfate of marine origin (Ateocollagen) marketed by Engelhard Lyon under the name marine filling spheres; spheres of hyaluronic acid such as those sold by the company Engelhard Lyon.
Agents desquamants additionnelsAdditional desquamating agents
Comme agents desquamants, on pourra citer les beta-hydroxyacides, en particulier l’acide salicylique et ses dérivés autres que l’acide n-octanoyl 5-salicylique ; l’urée ; les acides glycolique, citrique, lactique, tartrique, malique ou mandélique ; l’acide 4-(2-hydroxyéthyl)piperazine-l-propanesulfonique (HEPES) ; l’extrait de Saphora japonica ; le miel ; le N-acétyl glucosamine ; le méthyl glycine diacétate de sodium, les alpha-hydroxy acides (AHA), les Beta-hydroxy acides (BHA), et leurs mélanges.As desquamating agents, mention may be made of beta-hydroxy acids, in particular salicylic acid and its derivatives other than n-octanoyl-5-salicylic acid; urea; glycolic, citric, lactic, tartaric, malic or mandelic acids; 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid (HEPES); Saphora japonica extract; honey ; N-acetyl glucosamine; sodium methyl glycine diacetate, alpha-hydroxy acids (AHA), beta-hydroxy acids (BHA), and mixtures thereof.
Agents antioxydantsAntioxidants
Comme agents antioxydants, on peut plus particulièrement citer le tocophérol et ses esters, en particulier l'acétate de tocophérol ; l’EDTA, l’acide ascorbique et ses dérivés, en particulier l’ascorbyl magnésium phosphate et l’ascorbyl glucoside ; les chélatants, tels que le BHT, le BHA, le N,N’-bis(3,4,5-triméthoxybenzyl) éthylenediamine et ses sels, et leurs mélanges.As antioxidants, there may be mentioned more specifically tocopherol and its esters, in particular tocopherol acetate; EDTA, ascorbic acid and its derivatives, in particular ascorbyl magnesium phosphate and ascorbyl glucoside; chelating agents, such as BHT, BHA, N, N'-bis (3,4,5-trimethoxybenzyl) ethylenediamine and its salts, and mixtures thereof.
Agents dermodécontractants ou dermorelaxantsDermodecontracting agents or dermorelaxants
Comme agents dermodécontractants ou dermorelaxants, on peut citer tout particulièrement le gluconate de manganèse, le wild yam, la criste marine, la glycine et l’alvérine.As dermodecontracting or dermorelaxing agents, mention may be made especially of manganese gluconate, wild yam, sea fennel, glycine and alverine.
Actifs stimulants la synthèse de macromolécules dermiques et/ou épidermiques et/ou empêchant leur dégradationStimulating active ingredients the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation
Comme actifs stimulant la synthèse de macromolécules dermiques et/ou épidermiques et/ou empêchant leur dégradation, on peut citer : les peptides extraits de végétaux, tels que l'hydrolysat de soja commercialisé par la société BASF Beauty Care Solutions sous la dénomination commerciale Phytokine® l’extrait de malt tel que commercialisé sous la dénomination Collalift® par la société BASF BCS; les peptides de riz tel que le Nutripeptide® de SILAB, ou encore un extrait de peptides de riz tel que la Colhibin® de Pentapharm DSM, le méthylsilanol mannuronate tel que l’Algisium C® commercialisé par Exsymol ; un extrait de vaccinium myrtillus tel que ceux décrits dans la demande FR-A-2 814 950 ; l'extrait de lupin commercialisé par la société SILAB sous la dénomination commerciale Structurine®, et leurs mélanges, l’hydrolat de verveine.As active agents stimulating the synthesis of dermal and / or epidermal macromolecules and / or preventing their degradation, mention may be made of: peptides extracted from plants, such as the soy hydrolyzate marketed by BASF Beauty Care Solutions under the trade name Phytokine® malt extract as marketed under the name Collalift® by BASF BCS; rice peptides such as Nutripeptide® from SILAB, or an extract of rice peptides such as Colhibin® from Pentapharm DSM, methylsilanol mannuronate such as Algisium C® marketed by Exsymol; an extract of vaccinium myrtillus such as those described in FR-A-2 814 950; the lupine extract marketed by Silab under the trade name Structurine®, and mixtures thereof, verbena hydrosol.
Agents dépigmentantsDepigmenting agents
Comme agents dépigmentants, on peut citer les céramides, la vitamine C et ses dérivés et notamment la vit CG, CP et 3-0 éthyl vitamine C, l’alpha et la béta arbutine, l’acide férulique, l’acide kojique, le résorcinol et ses dérivés, le D calcium panthéteine sulfonate, l’acide lipoique, l’acide ellagique, la vitamine B3, le phényléthyl résorcinol comme le Symwhite 377® de la société Symrise, une eau de fruit de kiwi (Actinidia chinensis) commercialisée par Gattefosse, un extrait de racine de Paeonia suffructicosa tel que celui commercialisé par la société Ichimaru Pharcos sous la dénomination Botanpi Liquid B®, un extrait de sucre brun (Saccharum officinarum), tel que l’extrait de mélasse commercialisé par la société Taiyo Kagaku sous la dénomination Molasses Liquid, un mélange d’acide undecylenique et phénylalanine undecylenoyl, tel que le Sepiwhite MSH® de Seppic.As depigmenting agents, there may be mentioned ceramides, vitamin C and its derivatives and in particular the vit CG, CP and 3-0 ethyl vitamin C, alpha and beta arbutin, ferulic acid, kojic acid, resorcinol and its derivatives, D calcium panthetine sulfonate, lipoic acid, ellagic acid, vitamin B3, phenylethyl resorcinol such as Symwhite 377® from Symrise, a kiwi fruit water (Actinidia chinensis) marketed by Gattefosse, an extract of Paeonia suffructicosa root such as that marketed by the company Ichimaru Pharcos under the name Botanpi Liquid B®, a brown sugar extract (Saccharum officinarum), such as the molasses extract marketed by the company Taiyo Kagaku under the name Molasses Liquid, a mixture of undecylenic acid and phenylalanine undecylenoyl, such as Sepiwhite MSH® from Seppic.
Agents déodorantsDeodorants
Comme agents déodorants conformes à l’invention, on peut citer les huiles essentielles, des agents bactériostatiques ou des agents bactéricides agissant sur les germes des odeurs axillaires, comme le 2,4,4'-trichloro-2'-hydroxydiphényléther (®Triclosan), le 2,4-dichloro-2'-hydroxydiphényléther, le 3’,4’,5’-trichlorosalicylanilide, la l-(3’,4’- dichloropheny 1)-3-(4’-chlorophenyl)urée (®Triclocarban) ou le 3,7,11-triméthyldodéca-2,5,10-triénol (®Farnesol).As deodorants according to the invention, mention may be made of essential oils, bacteriostatic agents or bactericidal agents acting on the germs of axillary odors, such as 2,4,4'-trichloro-2'-hydroxydiphenyl ether (®Triclosan) 2,4-dichloro-2'-hydroxydiphenyl ether, 3 ', 4', 5'-trichlorosalicylanilide, 1- (3 ', 4'-dichlorophenyl) -3- (4'-chlorophenyl) urea (® Triclocarban) or 3,7,11-trimethyldodeca-2,5,10-trienol (®Farnesol).
Des agents déodorants conformes à l’invention peuvent également être choisis parmi les sels d’ammonium quaternaires comme les sels de cetyltrimethylammonium, les sels de cétylpyridinium , le DPTA (acide 1,3-diaminopropanetétraacétique), le 1,2 decanediol (Symclariol de la société Symrise) ; les dérivés de glycérine comme par exemple le Caprylic/Capric Glycerides (CAPMUL MCM de Abitec), le caprylate ou caprate de Glycerol (DERMOSOFT GMCY et DERMOSOFT GMC respectivement de STRAETMANS), le Polyglyceryl-2 Caprate (DERMOSOFT DGMC de STRAETMANS) ; les dérivés de biguanide comme les sels de polyhexaméthylène biguanide ; la chlorhexidine et ses sels; et le 4-Phenyl-4,4-dimethyl-2butanol (SYMDEO MPP de Symrise).Deodorant agents in accordance with the invention may also be chosen from quaternary ammonium salts, such as cetyltrimethylammonium salts, cetylpyridinium salts, DPTA (1,3-diaminopropanetetraacetic acid), 1,2-decanediol (Symclariol de la Symrise company); glycerol derivatives, for example Caprylic / Capric Glycerides (CAPMUL MCM from Abitec), caprylate or Glycerol caprate (DERMOSOFT GMCY and DERMOSOFT GMC respectively from STRAETMANS), Polyglyceryl-2 Caprate (DERMOSOFT DG ™ from STRAETMANS); biguanide derivatives such as polyhexamethylene biguanide salts; chlorhexidine and its salts; and 4-Phenyl-4,4-dimethyl-2-butanol (SYMDEO MPP from Symrise).
Peuvent encore être cités comme agents déodorants les sels de zinc comme le salicylate de zinc, le gluconate de zinc, le pidolate de zinc ; le sulfate de zinc, le chlorure de zinc, le lactate de zinc, le phénolsulfonate de zinc ou l’acide salicylique et ses dérivés tels que l’acide n-octanoyl-5-salicylique.Zinc salts such as zinc salicylate, zinc gluconate, zinc pidolate can also be mentioned as deodorant agents; zinc sulphate, zinc chloride, zinc lactate, zinc phenolsulfonate or salicylic acid and its derivatives such as n-octanoyl-5-salicylic acid.
En outre, des agents déodorants selon l’invention peuvent être choisis parmi les absorbeurs d’odeur comme les ricinoléates de zinc, le bicarbonate de sodium ; les Zéolithes métalliques ou non, les cyclodextrines.In addition, deodorants according to the invention may be chosen from odor absorbers such as zinc ricinoleates, sodium bicarbonate; metallic zeolites or not, cyclodextrins.
Il peut s’agit également d’un agent chélatant tel que la DISSOLVINE GL-47-S de Akzo Nobel, EDTA ; DPTA.It may also be a chelating agent such as Akzo Nobel DISSOLVINE GL-47-S, EDTA; DTPA.
Il peut encore s’agir d’inhibiteur enzymatique tel que le tri éthyle citrate.It may still be enzymatic inhibitor such as triethyl citrate.
En cas d’incompatibilité ou pour les stabiliser, certains des agents mentionnés ci-dessus peuvent être incorporés dans des sphérules, notamment des vésicules ioniques ou non-ioniques et/ou des particules (capsules et/ou sphères).In case of incompatibility or to stabilize them, some of the agents mentioned above may be incorporated in spherules, especially ionic or nonionic vesicles and / or particles (capsules and / or spheres).
Bien entendu, les agents déodorants pouvant être présents dans une composition conforme à l’invention ne doivent pas altérer les propriétés avantageuses de la composition indiquées précédemment.Of course, the deodorant agents that may be present in a composition according to the invention must not alter the advantageous properties of the composition indicated above.
La composition selon l’invention peut avoir la forme d'un produit de soin ou de maquillage du visage et/ou du corps, et être conditionnée par exemple sous forme de crème en pot ou de fluide en tube ou en flacon pompe.The composition according to the invention may have the form of a skincare or make-up product for the face and / or the body, and may be packaged, for example, in the form of potted cream or fluid in a tube or in a pump bottle.
Il relève des opérations de routine de l’homme de l’art d’ajuster la nature et la quantité des additifs présents dans les compositions conformes à l’invention, de telle sorte que les propriétés cosmétiques désirées de celles-ci n’en soient pas affectées.It is routine for those skilled in the art to adjust the nature and quantity of the additives present in the compositions according to the invention, so that the desired cosmetic properties thereof are not not affected.
Selon un autre mode de réalisation, une composition de l’invention peut avantageusement se présenter sous la forme d’une composition de base de maquillage pour le maquillage.According to another embodiment, a composition of the invention may advantageously be in the form of a makeup base composition for makeup.
Selon un autre mode de réalisation, une composition de l’invention peut avantageusement se présenter sous la forme d’un fond de teint.According to another embodiment, a composition of the invention may advantageously be in the form of a foundation.
De telles compositions sont notamment préparées selon les connaissances générales de l’homme de l’art.Such compositions are especially prepared according to the general knowledge of those skilled in the art.
Dans toute la description, y compris les revendications, l’expression « comportant un » doit être comprise comme étant synonyme de « comportant au moins un », sauf si le contraire est spécifié.Throughout the description, including the claims, the phrase "having one" should be understood as being synonymous with "having at least one", unless the opposite is specified.
Les expressions « compris entre ... et ...» et « allant de ... à ... » doivent se comprendre bornes incluses, sauf si le contraire est spécifié. L’invention est illustrée plus en détail par les exemples présentés ci-après. Sauf indication contraire, les quantités indiquées sont exprimées en pourcentage massique.Expressions "between ... and ..." and "from ... to ..." must be understood as inclusive terms unless otherwise specified. The invention is illustrated in more detail by the examples presented hereinafter. Unless otherwise indicated, the quantities indicated are expressed as a percentage by mass.
EXEMPLESEXAMPLES
Dans les tableaux suivants, la quantité de chaque composé est donnée en pourcentage en poids de matière active par rapport au poids total de la composition.In the following tables, the amount of each compound is given as a percentage by weight of active ingredient relative to the total weight of the composition.
Préparation des compositionsPreparation of compositions
Les compositions sont préparées au Rayneri selon le protocole suivant : - l’eau est pesée dans le becher de préparation, - l’acide spiculisporique est introduit sous agitation mécanique, étant insoluble dans l’eau, il reste sous forme de poudre, - la base notamment l’arginine est ajoutée sous agitation mécanique, le mélange des poudres se dissous au fur et à mesure, la solution devient totalement translucide après 5min d’agitation, - la ou les huiles sont introduite(s), toujours sous agitation et l’agitation est maintenue 10 minutes à 700-1000 RPM en fonction de la viscosité du milieu. - Le conservateur est ajouté ainsi que de l’eau qui permet d’atteindre la concentration visée.The compositions are prepared with Rayneri according to the following protocol: the water is weighed in the preparation beaker, the spiculisporic acid is introduced with mechanical stirring, being insoluble in water, it remains in the form of a powder, the In particular, arginine is added with mechanical stirring, the mixture of the powders dissolves as the solution becomes totally translucent after stirring for 5 minutes, the oil (s) are introduced (s), still with stirring and The stirring is maintained for 10 minutes at 700-1000 RPM depending on the viscosity of the medium. - The preservative is added along with water to reach the target concentration.
Préparations des filmsPreparations of the films
Les films sont préparés à l’aide d’un tire-film qui se présente sous la forme d’un bras mécanique qui balaie une surface plane à une vitesse contrôlée. L’épaisseur des films est contrôlée à l’aide d‘éprouvettes d’épaisseurs de fentes précises. Le film est ensuite laissé à l’air libre afin de sécher et le comportement au séchage est observé. Le comportement au séchage reflète la façon dont le tension-actif structure la phase grasse au séchage ainsi que la résistance du film obtenu à l’humidité ambiante. Série 1 -Emulsions comprenant un mono-sel d’arginine de l’acide spiculisporiqueThe films are prepared using a film puller which is in the form of a mechanical arm which sweeps a flat surface at a controlled speed. The thickness of the films is controlled using specimens of precise slot thicknesses. The film is then left in the open to dry and the drying behavior is observed. The drying behavior reflects the way in which the active-tension structures the fatty phase during drying as well as the resistance of the film obtained to the ambient humidity. Series 1 -Emulsions comprising a mono-salt of arginine of spiculisporic acid
Tableau 1Table 1
RésultatsResults
Exemples conformes L’exemple 1 comprenant 5 % de mono-sel d’arginine de l’acide spiculisporique conduit, après séchage, à la formation d’un film homogène et stable. Le film reste stable après stockage pendant deux semaines à l’air libre et à température ambiante. En effet on n’observe pas de coalescence de 1 émulsion ni de séparation des phases. Le film obtenu est sec et « rigide » en ce sens qu’il peut être manipulé. L’exemple 2 comprenant 1 % de mono-sel d’arginine de l’acide spiculisporique conduit, après séchage, à la formation d’un film homogène et stable. Le film est stable après stockage pendant deux semaines à l’air libre et à température ambiante. En effet on n’observe pas de coalescence de 1 émulsion ni de séparation des phases.Conforming examples Example 1 comprising 5% of arginine mono-salt of spiculisporic acid leads, after drying, to the formation of a homogeneous and stable film. The film remains stable after storage for two weeks in the open air and at room temperature. In fact, no coalescence of the emulsion or phase separation is observed. The resulting film is dry and "rigid" in that it can be manipulated. Example 2 comprising 1% of arginine mono-salt of spiculisporic acid leads, after drying, to the formation of a homogeneous and stable film. The film is stable after storage for two weeks in the open air and at room temperature. In fact, no coalescence of the emulsion or phase separation is observed.
Exemples comparatifs L’exemple A comprenant 5 % de mono-sel d’arginine de l’acide spiculisporique et 5 % de glycérine conduit, après séchage, à la formation d’un film non-homogène qui comporte des trous. La stabilité du film est mauvaise. Le film devient rapidement gras, collant, il ne peut pas être manipulé.Comparative Examples Example A comprising 5% arginine mono-salt of spiculisporic acid and 5% glycerine leads, after drying, to the formation of a non-homogeneous film which has holes. The stability of the film is bad. The film quickly becomes greasy, sticky, it can not be manipulated.
Au bout d’une heure, on observe une nette séparation des phases de l’émulsion.After one hour, there is a clear separation of the phases of the emulsion.
Les mêmes résultats ont été observés en remplaçant les 5 % de glycérine par 5 % de propanediol. L’émulsion de l’exemple B, sans acide spiculisporique, comprenant 1 % de xanthane n’est pas stable, on observe un déphasage rapidement apres la préparation. Par ailleurs cette émulsion ne conduit pas à un film homogène et stable. Cet exemple montre que le xanthane seul ne permet pas l’obtention d’une composition présentant des propriétés filmogènes. L’émulsion de l’exemple C comprenant 5 % de mono-sel de potassium de l’acide spiculisporique est stable après la préparation mais au bout de 10 heures, l’émulsion présente des cristaux. Le film obtenu après séchage présente rapidement un déphasage. Série 2 -Emulsions comprenant un sel d’arginine de l’acide spiculisporique- variation de la phase grasseThe same results were observed by replacing the 5% glycerin with 5% propanediol. The emulsion of Example B, without spiculisporic acid, comprising 1% of xanthan is not stable, a phase shift is observed rapidly after the preparation. Moreover, this emulsion does not lead to a homogeneous and stable film. This example shows that xanthan alone does not make it possible to obtain a composition having film-forming properties. The emulsion of Example C comprising 5% potassium mono-salt of spiculisporic acid is stable after preparation but after 10 hours the emulsion has crystals. The film obtained after drying rapidly has a phase shift. Series 2 - Emulsions comprising an arginine salt of spiculisporic acid - variation of the fatty phase
Tableau 2Table 2
RésultatsResults
Des émulsions ont été préparées en utilisant des huiles de polarité très différentes : de la moins polaire (squalane) à la plus polaire (huile d’olive). Dans tous les cas, des émulsions stables ont été obtenues conduisant à des films de bonne qualité. Série 3 -Emulsions comprenant un sel d’arginine de l’acide spiculisporique- variation du taux de phase grasseEmulsions were prepared using oils of very different polarity: from less polar (squalane) to more polar (olive oil). In all cases, stable emulsions were obtained leading to good quality films. Series 3 - Emulsions comprising arginine salt of spiculisporic acid - change in fat phase rate
Tableau 3Table 3
RésultatsResults
Toutes les émulsions LEE obtenues, même à fort taux de phase grasse, sont stables et conduisent à des films de bonne qualité : ces films sont homogènes, présentent une bonne tenue, et un toucher sec et non gras. Série 4 -Emulsions comprenant des polymères filmoeènes ou un tensioactif synthétiqueAll LEE emulsions obtained, even with a high fat content, are stable and lead to good quality films: these films are homogeneous, have good performance, and a dry, non-greasy feel. Series 4 -Emulsions comprising filmoene polymers or a synthetic surfactant
Tableau 4Table 4
RésultatsResults
Dans la composition de l’exemple comparatif D sont utilisés du SLG, (tensioactif synthétique) et du xanthane pour stabiliser l’émulsion formée et pouvoir préparer un film. Le film ainsi obtenu s’étale bien mais n’est pas stable après séchage puisqu’on observe de la coalescence.In the composition of Comparative Example D, SLG (synthetic surfactant) and xanthan are used to stabilize the emulsion formed and to be able to prepare a film. The film thus obtained spreads well but is not stable after drying since there is coalescence.
Dans chacune des compositions des exemples comparatifs E et F, un polymère filmogène est utilisé, ces polymères ne permettent pas de faire des émulsions stables et les films obtenus sont inhomogènes. Les polymères testés ne permettent pas de stabiliser un film gras.In each of the compositions of Comparative Examples E and F, a film-forming polymer is used, these polymers do not make it possible to make stable emulsions and the films obtained are inhomogeneous. The polymers tested do not make it possible to stabilize a greasy film.
Claims (19)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1563240A FR3046066B1 (en) | 2015-12-23 | 2015-12-23 | COMPOSITION BASED ON SPICULISPORIC ACID |
EP16829084.9A EP3393446B1 (en) | 2015-12-23 | 2016-12-23 | Spiculisporic acid-based composition |
PCT/EP2016/082590 WO2017109192A2 (en) | 2015-12-23 | 2016-12-23 | Spiculisporic acid-based composition |
US16/065,255 US20210205185A1 (en) | 2015-12-23 | 2016-12-23 | Spiculisporic acid-based composition |
CN202310042829.7A CN116035934A (en) | 2015-12-23 | 2016-12-23 | Composition based on paecilomyces acid |
ES16829084T ES2945058T3 (en) | 2015-12-23 | 2016-12-23 | Composition based on spiculisporic acid |
CN201680082462.XA CN108697611A (en) | 2015-12-23 | 2016-12-23 | Composition based on spiculisporic acid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1563240A FR3046066B1 (en) | 2015-12-23 | 2015-12-23 | COMPOSITION BASED ON SPICULISPORIC ACID |
FR1563240 | 2015-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3046066A1 true FR3046066A1 (en) | 2017-06-30 |
FR3046066B1 FR3046066B1 (en) | 2020-02-21 |
Family
ID=56068996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1563240A Active FR3046066B1 (en) | 2015-12-23 | 2015-12-23 | COMPOSITION BASED ON SPICULISPORIC ACID |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3046066B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3075049A1 (en) * | 2017-12-19 | 2019-06-21 | L'oreal | AQUEOUS FOAMING COMPOSITION COMPRISING SPICULISPORIC ACID, ALKYL POLYGLYCOSIDE AND POLYSACCHARIDE |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0559389A (en) * | 1991-09-02 | 1993-03-09 | Kyodo Yushi Kk | Organic water-soluble moisture-conditioning rolling lubricant |
WO2015067785A1 (en) * | 2013-11-08 | 2015-05-14 | L'oreal | Cosmetic compositions comprising spiculisporic acid and at least one sulfate and/or sulfonate surfactant |
WO2015067784A1 (en) * | 2013-11-08 | 2015-05-14 | L'oreal | Cosmetic compositions comprising spiculisporic acid and an ester of fatty acid and (poly)glycerol optionally polyoxyalkylenated |
WO2016005707A1 (en) * | 2014-07-10 | 2016-01-14 | L'oreal | Cosmetic use of spiculisporic acid as a deodorant active agent |
-
2015
- 2015-12-23 FR FR1563240A patent/FR3046066B1/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0559389A (en) * | 1991-09-02 | 1993-03-09 | Kyodo Yushi Kk | Organic water-soluble moisture-conditioning rolling lubricant |
WO2015067785A1 (en) * | 2013-11-08 | 2015-05-14 | L'oreal | Cosmetic compositions comprising spiculisporic acid and at least one sulfate and/or sulfonate surfactant |
WO2015067784A1 (en) * | 2013-11-08 | 2015-05-14 | L'oreal | Cosmetic compositions comprising spiculisporic acid and an ester of fatty acid and (poly)glycerol optionally polyoxyalkylenated |
WO2016005707A1 (en) * | 2014-07-10 | 2016-01-14 | L'oreal | Cosmetic use of spiculisporic acid as a deodorant active agent |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3075049A1 (en) * | 2017-12-19 | 2019-06-21 | L'oreal | AQUEOUS FOAMING COMPOSITION COMPRISING SPICULISPORIC ACID, ALKYL POLYGLYCOSIDE AND POLYSACCHARIDE |
WO2019121706A1 (en) * | 2017-12-19 | 2019-06-27 | L'oreal | Foaming aqueous composition comprising spiculisporic acid, an alkyl polyglycoside and a polysaccharide |
Also Published As
Publication number | Publication date |
---|---|
FR3046066B1 (en) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3554462A1 (en) | Method for improving the sensorial properties of oil-in-water emulsions | |
FR3004454A1 (en) | NEW WATER-IN-OIL EMULSIONS WITH HIGH AQUEOUS PHASE CONTENT, LIQUID CONSISTENCY AND STORAGE STABILITY | |
JP2011506556A (en) | Water-in-oil (W / O) emulsions stabilized by lipophilic emulsifiers and hydrophobically modified polysaccharides | |
EP2459155A2 (en) | Oil-in-water emulsion having improved sensory properties | |
FR2944972A1 (en) | COSMETIC COMPOSITION COMPRISING A SURFACTANT HLB HIGHER OR EQUAL TO 12 AND A COATED PIGMENT | |
FR2977486A1 (en) | COSMETIC COMPOSITIONS IN THE FORM OF WATER-IN-OIL EMULSIONS COMPRISING A JASMONIC ACID DERIVATIVE | |
FR2992173A1 (en) | COSMETIC HEALING PROCESS FOR SKIN AND / OR LIP | |
EP3393446B1 (en) | Spiculisporic acid-based composition | |
EP1795176A2 (en) | cosmetic foam compositions having reduced density | |
FR3117799A1 (en) | Composition comprising aqueous gelling agents, surfactant, oils, fillers and ascorbic acid | |
FR2977487A1 (en) | COSMETIC COMPOSITIONS IN THE FORM OF WATER-IN-OIL EMULSIONS COMPRISING A JASMONIC ACID DERIVATIVE AND A SILICONE SURFACTANT | |
EP3452007A1 (en) | Process for short-term improvement of the moisturization state of human skin epidermis; novel moisturizing compositions | |
EP1559396A1 (en) | Process for preparing a composition for the cosmetic treatment of keratinous materials on the basis of a pressurized fluid and cosmetically active liquid compound entrapped in particles | |
FR2945208A1 (en) | Cosmetic and/or dermatological composition of oil-in-water emulsion, useful e.g. as foundation, comprises oily phase dispersed in aqueous phase and coloring material in solid particles form, and emulsifier system e.g. alkyl poly glucoside | |
WO2020193900A1 (en) | Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same | |
WO2005046627A2 (en) | Make-up or lip care composition comprising an oil in water emulsion and a hydrophilic active agent | |
FR2979232A1 (en) | Composition, useful for e.g. making up and/or caring of skin and preventing skin aging, comprising aqueous phase dispersed in fatty phase, comprises jasmonic acid derivatives and emulsifying silicone elastomer comprising hydrophilic chain | |
FR3046066A1 (en) | COMPOSITION BASED ON SPICULISPORIC ACID | |
FR2927535A1 (en) | Composition in water-in-oil emulsion comprising an aqueous phase dispersed in oily phase, useful for non-therapeutic process e.g. for care, make-up, or make-up removal of the skin, comprises fatty acid ester and polyol, and linear polyol | |
FR2924932A1 (en) | Caring wrinkled skin to reduce the lines, comprises topical application of first composition having aqueous phase and insoluble antiwrinkle active agent, and topical application of second composition having fat phase and/or aqueous phase | |
FR3007974A1 (en) | COMPOSITION COMPRISING A C-GLYCOSIDE DERIVATIVE OR A CUCURBIC ACID DERIVATIVE, A PASTY FATTY BODY AND A NON-IONIC DERIVATIVE OF MODIFIED HYDROPHOBIC CELLULOSE | |
FR2983709A1 (en) | Oil-in-water emulsion having specified pH value, used to package article, comprises nonionic emulsifying system comprising e.g. fatty acid ether and polyalkylene glycol, and fatty alcohol, lipophilic UV filter and skin coloring agent | |
FR2925362A1 (en) | Composition in water-in-oil emulsion form, useful e.g. for non-therapeutic care, make-up/make-up removal of e.g. skin comprises continuous oily phase having fatty acid ester and polyol, aqueous phase and modified hydrophobic polysaccharide | |
EP3621576B1 (en) | Photostable compostion comprising compsite particles of perlite/titanium/silica | |
EP3760182A1 (en) | Long-lasting solid cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20170630 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |